<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>6451933</id><passage><infon key="year">2019</infon><infon key="type">front</infon><infon key="name_42">surname:Ferrari;given-names:Michel D.</infon><infon key="name_43">surname:Verrotti;given-names:Alberto</infon><infon key="name_40">surname:Banu;given-names:Selina</infon><infon key="name_41">surname:Veggiotti;given-names:Pierangelo</infon><infon key="name_46">surname:Garavaglia;given-names:Barbara</infon><infon key="name_47">surname:Scuderi;given-names:Carmela</infon><infon key="name_44">surname:Marseglia;given-names:Gian Luigi</infon><infon key="name_45">surname:Savasta;given-names:Salvatore</infon><infon key="name_48">surname:Borgione;given-names:Eugenia</infon><infon key="name_49">surname:Dipasquale;given-names:Valeria</infon><infon key="fpage">721</infon><infon key="issue">4</infon><infon key="name_31">surname:Perez-Duenas;given-names:Belen</infon><infon key="name_32">surname:Di Rosa;given-names:Gabriella</infon><infon key="name_30">surname:Cormand;given-names:Bru</infon><infon key="name_35">surname:Sultan;given-names:Tipu</infon><infon key="name_36">surname:Kirmani;given-names:Salman</infon><infon key="name_33">surname:Pironti;given-names:Erica</infon><infon key="name_34">surname:Goraya;given-names:Jatinder S.</infon><infon key="name_39">surname:Mine;given-names:Jun</infon><infon key="name_37">surname:Ibrahim;given-names:Shahnaz</infon><infon key="name_38">surname:Jan;given-names:Farida</infon><infon key="name_3">surname:Spaeth;given-names:Christine G.</infon><infon key="name_2">surname:Llano-Rivas;given-names:Isabel</infon><infon key="name_1">surname:Malintan;given-names:Nancy T.</infon><infon key="name_0">surname:Salpietro;given-names:Vincenzo</infon><infon key="name_60">surname:Malintan;given-names:Nancy</infon><infon key="name_61">surname:Zanetti;given-names:Maria Natalia</infon><infon key="name_64">surname:Kullmann;given-names:Dimitri M.</infon><infon key="name_65">surname:Houlden;given-names:Henry</infon><infon key="name_62">surname:Hanna;given-names:Michael G.</infon><infon key="name_63">surname:Rothman;given-names:James E.</infon><infon key="name_68">surname:Fortuna;given-names:Sara</infon><infon key="name_69">surname:Dauber;given-names:Andrew</infon><infon key="name_66">surname:Bello;given-names:Oscar D.</infon><infon key="name_67">surname:De Zorzi;given-names:Rita</infon><infon key="name_50">surname:Cutrupi;given-names:Maria Concetta</infon><infon key="name_53">surname:Pineda-Marfa';given-names:Mercedes</infon><infon key="name_54">surname:Munell;given-names:Francina</infon><infon key="name_51">surname:Portaro;given-names:Simona</infon><infon key="name_52">surname:Sanchez;given-names:Benigno Monteagudo</infon><infon key="name_57">surname:Heimer;given-names:Gali</infon><infon key="name_58">surname:Papacostas;given-names:Savvas</infon><infon key="name_55">surname:Macaya;given-names:Alfons</infon><infon key="name_56">surname:Boles;given-names:Richard</infon><infon key="kwd">SNARE vesicle fusion neuronal exocytosis VAMP2 synaptobrevin neurodevelopmental disorders synaptopathy autism movement disorders epilepsy</infon><infon key="name_59">surname:Manole;given-names:Andreea</infon><infon key="notes">Published: March 28, 2019</infon><infon key="name_82">surname:Krishnakumar;given-names:Shyam S.</infon><infon key="name_83">surname:Houlden;given-names:Henry</infon><infon key="name_80">surname:Kullmann;given-names:Dimitri M.</infon><infon key="name_81">surname:Rothman;given-names:James E.</infon><infon key="section_type">TITLE</infon><infon key="name_71">surname:Sultan;given-names:Tipu</infon><infon key="name_72">surname:Mankad;given-names:Kshitij</infon><infon key="name_70">surname:Alkhawaja;given-names:Mariam</infon><infon key="name_75">surname:Mau-Them;given-names:Frederic Tran</infon><infon key="volume">104</infon><infon key="license">This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_76">surname:Faivre;given-names:Laurence</infon><infon key="name_73">surname:Vitobello;given-names:Antonio</infon><infon key="name_74">surname:Thomas;given-names:Quentin</infon><infon key="name_79">surname:Macaya;given-names:Alfons</infon><infon key="name_77">surname:Martinez-Azorin;given-names:Francisco</infon><infon key="name_78">surname:Prada;given-names:Carlos E.</infon><infon key="name_9">surname:David;given-names:Emanuele</infon><infon key="name_8">surname:Chimenz;given-names:Roberto</infon><infon key="name_7">surname:Cutrupi;given-names:Maria C.</infon><infon key="name_6">surname:Vandrovcova;given-names:Jana</infon><infon key="name_5">surname:Striano;given-names:Pasquale</infon><infon key="name_4">surname:Efthymiou;given-names:Stephanie</infon><infon key="article-id_publisher-id">S0002-9297(19)30061-8</infon><infon key="article-id_doi">10.1016/j.ajhg.2019.02.016</infon><infon key="title">Keywords</infon><infon key="name_20">surname:Aguennouz;given-names:Mhammed</infon><infon key="name_21">surname:Karashova;given-names:Blagovesta</infon><infon key="name_24">surname:Tincheva;given-names:Radka</infon><infon key="name_25">surname:Van Maldergem;given-names:Lionel</infon><infon key="name_22">surname:Avdjieva;given-names:Daniela</infon><infon key="name_23">surname:Kathom;given-names:Hadil</infon><infon key="name_28">surname:Arning;given-names:Larissa</infon><infon key="name_29">surname:Timmann;given-names:Dagmar</infon><infon key="name_26">surname:Nachbauer;given-names:Wolfgang</infon><infon key="name_27">surname:Boesch;given-names:Sylvia</infon><infon key="lpage">730</infon><infon key="name_10">surname:Di Rosa;given-names:Gabriella</infon><infon key="name_13">surname:Martin-Hernandez;given-names:Elena</infon><infon key="name_14">surname:Zara;given-names:Federico</infon><infon key="name_11">surname:Marce-Grau;given-names:Anna</infon><infon key="name_12">surname:Raspall-Chaure;given-names:Miquel</infon><infon key="name_17">surname:Efthymiou;given-names:Stephanie</infon><infon key="name_18">surname:Kriouile;given-names:Yamna</infon><infon key="name_15">surname:Minetti;given-names:Carlo</infon><infon key="name_16">surname:Salpietro;given-names:Vincenzo</infon><infon key="name_19">surname:El Khorassani;given-names:Mohamed</infon><infon key="article-id_pmc">6451933</infon><infon key="article-id_pmid">30929742</infon><offset>0</offset><text>Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment</text><annotation id="2930"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="42" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>114</offset><text>VAMP2 encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous de novo mutations in VAMP2 in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying de novo non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by VAMP2 de novo mutations highlights the key roles of this gene in human brain development and function.</text><annotation id="2931"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="114" length="5" /><text>VAMP2</text></annotation><annotation id="2932"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="156" length="5" /><text>VAMP2</text></annotation><annotation id="2933"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="175" length="15" /><text>synaptobrevin-2</text></annotation><annotation id="2934"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="220" length="11" /><text>syntaxin-1A</text></annotation><annotation id="2935"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="236" length="34" /><text>synaptosomal-associated protein 25</text></annotation><annotation id="2936"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="272" length="6" /><text>SNAP25</text></annotation><annotation id="2937"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="281" length="5" /><text>VAMP2</text></annotation><annotation id="2938"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="354" length="5" /><text>VAMP2</text></annotation><annotation id="2939"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="502" length="5" /><text>VAMP2</text></annotation><annotation id="2940"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="846" length="5" /><text>VAMP2</text></annotation><annotation id="2941"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="1335" length="5" /><text>VAMP2</text></annotation><annotation id="2942"><infon key="type">Disease</infon><location offset="1312" length="12" /><text>synaptopathy</text></annotation><annotation id="2943"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="650" length="23" /><text>intellectual disability</text></annotation><annotation id="2944"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="1050" length="17" /><text>visual impairment</text></annotation><annotation id="2945"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="1188" length="5" /><text>lipid</text></annotation><annotation id="2946"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1400" length="5" /><text>human</text></annotation><annotation id="2947"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="551" length="27" /><text>neurodevelopmental disorder</text></annotation><annotation id="2948"><infon key="identifier">MESH:D000014</infon><infon key="type">Disease</infon><location offset="1117" length="36" /><text>electroencephalography abnormalities</text></annotation><annotation id="2949"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="1069" length="30" /><text>hyperkinetic movement disorder</text></annotation><annotation id="2950"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="1105" length="8" /><text>epilepsy</text></annotation><annotation id="2951"><infon key="identifier">MESH:D009123</infon><infon key="type">Disease</infon><location offset="596" length="15" /><text>axial hypotonia</text></annotation><annotation id="2952"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="679" length="17" /><text>autistic features</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1438</offset><text>Main Text</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1448</offset><text>Chemical synaptic transmission relies on precisely coordinated, activity-dependent neurotransmitter release. A fundamental step in this pathway is the fusion of synaptic vesicles with the presynaptic plasma membrane. Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate membrane fusion and are essential for the fusion of synaptic vesicles. At mammalian central nervous system (CNS) synapses, neuronal SNAREs consist of vesicle-associated membrane protein 2 (VAMP2, also called synaptobrevin-2) on the vesicle membrane (v-SNARE) and the binary complex of syntaxin1A (STX1A) and synaptosomal-associated protein 25 Kd (SNAP25) on the plasma membrane (target or t-SNARE). The v- and t-SNARE proteins assemble in a polarized manner starting from the N termini distal from the membranes and proceeding towards the C termini and are held together by discrete interacting residues (numbered -7 to +8), including 15 hydrophobic contacts and central ionic residues. This "zippering" process pulls the membranes together and provides the energy to fuse the lipid bilayers. The SNAREs alone are sufficient to drive fusion of synaptic vesicles, but this process is tightly regulated by a number of synaptic proteins to enable Ca2+-regulated neurotransmitter release. The key regulatory elements at excitatory CNS synapses include chaperones (Munc18 and Munc13), the primary Ca2+ sensor synaptotagmin-1, and the auxiliary protein complexin.</text><annotation id="2953"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="1910" length="37" /><text>vesicle-associated membrane protein 2</text></annotation><annotation id="2954"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="1949" length="5" /><text>VAMP2</text></annotation><annotation id="2955"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="1968" length="15" /><text>synaptobrevin-2</text></annotation><annotation id="2956"><infon key="identifier">10490</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">38178</infon><location offset="2010" length="7" /><text>v-SNARE</text></annotation><annotation id="2957"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="2045" length="10" /><text>syntaxin1A</text></annotation><annotation id="2958"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="2057" length="5" /><text>STX1A</text></annotation><annotation id="2959"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="2068" length="37" /><text>synaptosomal-associated protein 25 Kd</text></annotation><annotation id="2960"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="2107" length="6" /><text>SNAP25</text></annotation><annotation id="2961"><infon key="identifier">10497</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">31376</infon><location offset="2831" length="6" /><text>Munc13</text></annotation><annotation id="2962"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="2864" length="15" /><text>synaptotagmin-1</text></annotation><annotation id="2963"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="2537" length="5" /><text>lipid</text></annotation><annotation id="2964"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="2852" length="4" /><text>Ca2+</text></annotation><annotation id="2965"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="2704" length="4" /><text>Ca2+</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2923</offset><text>VAMP2 (MIM: 185881) encodes a neuronal v-SNARE essential for the fusion of synaptic vesicles at mammalian central nerve terminals. Introduction of specific engineered mutations affecting its SNARE motif has been reported to alter vesicle fusion in vitro by impairing either formation of the SNARE complex or the interaction of VAMP2 with other (auxiliary) presynaptic proteins. Vamp2-/- mice present severely decreased rates of both spontaneous and Ca2+-triggered synaptic-vesicle fusion, and these mice die immediately after birth. Also, synapses from VAMP2-deficient mice display changes in synaptic-vesicle morphology and size:and delayed stimulus-dependent endocytosis. Thus, VAMP2 exerts a complex influence on synaptic transmission; it plays fundamental roles in vesicle fusion, neurotransmitter release, and vesicle endocytosis. Despite the critical role of VAMP2 in presynaptic molecular events, little is known of the consequences of disrupted VAMP2 function in human neurodevelopment.</text><annotation id="2966"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="2923" length="5" /><text>VAMP2</text></annotation><annotation id="2967"><infon key="identifier">10490</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">38178</infon><location offset="2962" length="7" /><text>v-SNARE</text></annotation><annotation id="2968"><infon key="identifier">100410194</infon><infon key="type">Gene</infon><location offset="3250" length="5" /><text>VAMP2</text></annotation><annotation id="2969"><infon key="identifier">22318</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3301" length="5" /><text>Vamp2</text></annotation><annotation id="2970"><infon key="identifier">22318</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3476" length="5" /><text>VAMP2</text></annotation><annotation id="2971"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3603" length="5" /><text>VAMP2</text></annotation><annotation id="2972"><infon key="identifier">479491</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3788" length="5" /><text>VAMP2</text></annotation><annotation id="2973"><infon key="identifier">22318</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3876" length="5" /><text>VAMP2</text></annotation><annotation id="2974"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="3310" length="4" /><text>mice</text></annotation><annotation id="2975"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="3894" length="5" /><text>human</text></annotation><annotation id="2976"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="3422" length="4" /><text>mice</text></annotation><annotation id="2977"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="3492" length="4" /><text>mice</text></annotation><annotation id="2978"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="3372" length="4" /><text>Ca2+</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="type">table_caption</infon><offset>3926</offset><text>Clinical Features of Individuals with De Novo VAMP2 Mutations</text><annotation id="2979"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="3972" length="5" /><text>VAMP2</text></annotation><annotation id="2980"><infon key="type">Disease</infon><location offset="3967" length="4" /><text>Novo</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl1.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th&gt;&lt;bold&gt;Individual Number Gender Age&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Variant&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Growth/OFC&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Hypotonia/DD&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;ID&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Epileptic Seizures&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;EEG&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;ASD&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;RTT-Like Features&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Movement Disorder&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Central Visual Defects&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Speech Impairment&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Brain Imaging&lt;/bold&gt;&lt;/th&gt;&lt;th&gt;&lt;bold&gt;Additional Features&lt;/bold&gt;&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;1&lt;break/&gt;F&lt;break/&gt;3 yr&lt;/td&gt;&lt;td&gt;c.223T&amp;gt;C, p.Ser75Pro&lt;/td&gt;&lt;td&gt;normal&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;severe&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;high-voltage delta activity, sharp wave-slow wave complexes&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;stereotyped hand movements, absent purposeful hand movements&lt;/td&gt;&lt;td&gt;choreic movement,&lt;break/&gt;flapping, dystonic postures&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;absent speech&lt;/td&gt;&lt;td&gt;thin corpus callosum, delayed myelination&lt;/td&gt;&lt;td&gt;inability to walk&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;2&lt;break/&gt;M&lt;break/&gt;10 yr&lt;/td&gt;&lt;td&gt;c.233A&amp;gt;C, p.Glu78Ala&lt;/td&gt;&lt;td&gt;normal&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;severe&lt;/td&gt;&lt;td&gt;focal seizures, GTCS&lt;/td&gt;&lt;td&gt;fast rhythmic activity, sharp wave-slow wave complexes&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;body rocking, head banging, screaming, absent purposeful hand movements&lt;/td&gt;&lt;td&gt;generalized&lt;break/&gt;chorea&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;absent speech&lt;/td&gt;&lt;td&gt;unremarkable&lt;/td&gt;&lt;td&gt;abnormal behavior,&lt;break/&gt;self-injury,&lt;break/&gt;inability to walk&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;3&lt;break/&gt;M&lt;break/&gt;13yr&lt;/td&gt;&lt;td&gt;c.230T&amp;gt;C, p.Phe77Ser&lt;/td&gt;&lt;td&gt;normal&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;severe&lt;/td&gt;&lt;td&gt;infantile spasms,&lt;break/&gt;convulsive status epilepticus&lt;/td&gt;&lt;td&gt;disorganized EEG paroxysms&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;stereotyped hand movements, absent purposeful hand movements&lt;/td&gt;&lt;td&gt;choreic movement, myoclonic jerks&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;absent speech&lt;/td&gt;&lt;td&gt;unremarkable&lt;/td&gt;&lt;td&gt;abnormal behavior, inability to walk,&lt;break/&gt;severe constipation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;4&lt;break/&gt;M&lt;break/&gt;14yr&lt;/td&gt;&lt;td&gt;c.128_130delTGG, p.Val43del&lt;/td&gt;&lt;td&gt;normal&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;moderate&lt;/td&gt;&lt;td&gt;focal seizures&lt;/td&gt;&lt;td&gt;generalized and multifocal abnormalities&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;stereotyped hand movements (wringing), absent purposeful hand movements&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;only 5-10 spoken words&lt;/td&gt;&lt;td&gt;unremarkable&lt;/td&gt;&lt;td&gt;clumsiness, abnormal behavior&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;5&lt;break/&gt;F&lt;break/&gt;3 yr&lt;/td&gt;&lt;td&gt;c.135_137delCAT, p.Ile45del&lt;/td&gt;&lt;td&gt;normal&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;moderate&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;disorganized EEG paroxysms&lt;/td&gt;&lt;td&gt;yes&lt;/td&gt;&lt;td&gt;stereotyped hand movements (washing)&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;no&lt;/td&gt;&lt;td&gt;only 5 spoken words&lt;/td&gt;&lt;td&gt;unremarkable&lt;/td&gt;&lt;td&gt;abnormal behavior&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">tbl1</infon><infon key="type">table</infon><offset>3988</offset><text>Individual Number Gender Age Variant Growth/OFC Hypotonia/DD ID Epileptic Seizures EEG ASD RTT-Like Features Movement Disorder Central Visual Defects Speech Impairment Brain Imaging Additional Features   1F3 yr c.223T&gt;C, p.Ser75Pro normal yes severe no high-voltage delta activity, sharp wave-slow wave complexes yes stereotyped hand movements, absent purposeful hand movements choreic movement,flapping, dystonic postures yes absent speech thin corpus callosum, delayed myelination inability to walk   2M10 yr c.233A&gt;C, p.Glu78Ala normal yes severe focal seizures, GTCS fast rhythmic activity, sharp wave-slow wave complexes yes body rocking, head banging, screaming, absent purposeful hand movements generalizedchorea yes absent speech unremarkable abnormal behavior,self-injury,inability to walk   3M13yr c.230T&gt;C, p.Phe77Ser normal yes severe infantile spasms,convulsive status epilepticus disorganized EEG paroxysms yes stereotyped hand movements, absent purposeful hand movements choreic movement, myoclonic jerks yes absent speech unremarkable abnormal behavior, inability to walk,severe constipation   4M14yr c.128_130delTGG, p.Val43del normal yes moderate focal seizures generalized and multifocal abnormalities yes stereotyped hand movements (wringing), absent purposeful hand movements no no only 5-10 spoken words unremarkable clumsiness, abnormal behavior   5F3 yr c.135_137delCAT, p.Ile45del normal yes moderate no disorganized EEG paroxysms yes stereotyped hand movements (washing) no no only 5 spoken words unremarkable abnormal behavior   </text><annotation id="2981"><infon key="identifier">MESH:D013009</infon><infon key="type">Disease</infon><location offset="4779" length="7" /><text>to walk</text></annotation><annotation id="2982"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="4046" length="5" /><text>DD ID</text></annotation><annotation id="2983"><infon key="identifier">MESH:D009207</infon><infon key="type">Disease</infon><location offset="4992" length="15" /><text>myoclonic jerks</text></annotation><annotation id="2984"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="4123" length="14" /><text>Visual Defects</text></annotation><annotation id="2985"><infon key="identifier">MESH:D013009</infon><infon key="type">Disease</infon><location offset="4481" length="7" /><text>to walk</text></annotation><annotation id="2986"><infon key="identifier">MESH:D003711</infon><infon key="type">Disease</infon><location offset="4451" length="19" /><text>delayed myelination</text></annotation><annotation id="2987"><infon key="identifier">tmVar:p|DEL|45|I;HGVS:p.I45del;VariantGroup:7;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="5383" length="10" /><text>p.Ile45del</text></annotation><annotation id="2988"><infon key="identifier">MESH:D013036</infon><infon key="type">Disease</infon><location offset="4835" length="16" /><text>infantile spasms</text></annotation><annotation id="2989"><infon key="identifier">MESH:D013064</infon><infon key="type">Disease</infon><location offset="4138" length="17" /><text>Speech Impairment</text></annotation><annotation id="2990"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="4075" length="3" /><text>ASD</text></annotation><annotation id="2991"><infon key="identifier">MESH:D002819</infon><infon key="type">Disease</infon><location offset="4974" length="16" /><text>choreic movement</text></annotation><annotation id="2992"><infon key="type">Disease</infon><location offset="4554" length="4" /><text>GTCS</text></annotation><annotation id="2993"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="5153" length="14" /><text>focal seizures</text></annotation><annotation id="2994"><infon key="identifier">MESH:D054972</infon><infon key="type">Disease</infon><location offset="4393" length="17" /><text>dystonic postures</text></annotation><annotation id="2995"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="4209" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="2996"><infon key="identifier">tmVar:p|DEL|135_137|H;HGVS:p.H135_137del;VariantGroup:17;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="5366" length="15" /><text>c.135_137delCAT</text></annotation><annotation id="2997"><infon key="identifier">MESH:D001523</infon><infon key="type">Disease</infon><location offset="5339" length="17" /><text>abnormal behavior</text></annotation><annotation id="2998"><infon key="identifier">MESH:D012652</infon><infon key="type">Disease</infon><location offset="4757" length="11" /><text>self-injury</text></annotation><annotation id="2999"><infon key="identifier">MESH:D013009</infon><infon key="type">Disease</infon><location offset="5068" length="7" /><text>to walk</text></annotation><annotation id="3000"><infon key="identifier">tmVar:p|DEL|128_130|W;HGVS:p.W128_130del;VariantGroup:14;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="5105" length="15" /><text>c.128_130delTGG</text></annotation><annotation id="3001"><infon key="identifier">MESH:D013226</infon><infon key="type">Disease</infon><location offset="4852" length="29" /><text>convulsive status epilepticus</text></annotation><annotation id="3002"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="4509" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3003"><infon key="identifier">tmVar:c|SUB|A|233|C;HGVS:c.233A&gt;C;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">DNAMutation</infon><location offset="4499" length="8" /><text>c.233A&gt;C</text></annotation><annotation id="3004"><infon key="identifier">MESH:C563481</infon><infon key="type">Disease</infon><location offset="4032" length="13" /><text>OFC Hypotonia</text></annotation><annotation id="3005"><infon key="identifier">MESH:D009069</infon><infon key="type">Disease</infon><location offset="4097" length="17" /><text>Movement Disorder</text></annotation><annotation id="3006"><infon key="identifier">MESH:D003248</infon><infon key="type">Disease</infon><location offset="5083" length="12" /><text>constipation</text></annotation><annotation id="3007"><infon key="identifier">MESH:D006230</infon><infon key="type">Disease</infon><location offset="4317" length="14" /><text>hand movements</text></annotation><annotation id="3008"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="4333" length="32" /><text>absent purposeful hand movements</text></annotation><annotation id="3009"><infon key="identifier">MESH:D002819</infon><infon key="type">Disease</infon><location offset="4366" length="16" /><text>choreic movement</text></annotation><annotation id="3010"><infon key="identifier">tmVar:p|DEL|43|V;HGVS:p.V43del;VariantGroup:2;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="5122" length="10" /><text>p.Val43del</text></annotation><annotation id="3011"><infon key="identifier">MESH:D001523</infon><infon key="type">Disease</infon><location offset="5524" length="17" /><text>abnormal behavior</text></annotation><annotation id="3012"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="4538" length="14" /><text>focal seizures</text></annotation><annotation id="3013"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="4806" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3014"><infon key="identifier">MESH:D006230</infon><infon key="type">Disease</infon><location offset="5225" length="14" /><text>hand movements</text></annotation><annotation id="3015"><infon key="identifier">MESH:D001523</infon><infon key="type">Disease</infon><location offset="5039" length="17" /><text>abnormal behavior</text></annotation><annotation id="3016"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="4052" length="18" /><text>Epileptic Seizures</text></annotation><annotation id="3017"><infon key="identifier">tmVar:c|SUB|T|230|C;HGVS:c.230T&gt;C;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="4796" length="8" /><text>c.230T&gt;C</text></annotation><annotation id="3018"><infon key="identifier">tmVar:c|SUB|T|223|C;HGVS:c.223T&gt;C;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">DNAMutation</infon><location offset="4199" length="8" /><text>c.223T&gt;C</text></annotation><annotation id="3019"><infon key="identifier">MESH:D001523</infon><infon key="type">Disease</infon><location offset="4739" length="17" /><text>abnormal behavior</text></annotation><annotation id="3020"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="5252" length="32" /><text>absent purposeful hand movements</text></annotation><annotation id="3021"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="4657" length="32" /><text>absent purposeful hand movements</text></annotation><annotation id="3022"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="4941" length="32" /><text>absent purposeful hand movements</text></annotation><annotation id="3023"><infon key="identifier">MESH:D006230</infon><infon key="type">Disease</infon><location offset="4925" length="14" /><text>hand movements</text></annotation><annotation id="3024"><infon key="identifier">MESH:D006230</infon><infon key="type">Disease</infon><location offset="5460" length="14" /><text>hand movements</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="type">table_footnote</infon><offset>5547</offset><text>Abbreviations are as follows: ASD = autism spectrum disorder; DD = developmental delay; EEG = electroencephalography; FC = focal seizures; GTCS = generalized tonic-clonic seizures; ID = intellectual disability; and OFC = occipital-frontal circumference. Variants are named according to the GenBank: NM_014232 reference transcript.</text><annotation id="3025"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="5609" length="2" /><text>DD</text></annotation><annotation id="3026"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="5733" length="23" /><text>intellectual disability</text></annotation><annotation id="3027"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="5705" length="21" /><text>tonic-clonic seizures</text></annotation><annotation id="3028"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="5676" length="8" /><text>seizures</text></annotation><annotation id="3029"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="5577" length="3" /><text>ASD</text></annotation><annotation id="3030"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="5614" length="19" /><text>developmental delay</text></annotation><annotation id="3031"><infon key="identifier">MESH:D000067877</infon><infon key="type">Disease</infon><location offset="5583" length="24" /><text>autism spectrum disorder</text></annotation><annotation id="3032"><infon key="type">Disease</infon><location offset="5686" length="4" /><text>GTCS</text></annotation><annotation id="3033"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="5728" length="2" /><text>ID</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5878</offset><text>Here, we describe five unrelated individuals who had shown hypotonia since birth and who had intellectual disability (ID) with autistic features, including variable motor stereotypies resembling Rett syndrome (RTT), and, in some children, also central visual impairment, hyperkinetic movements, and epilepsy and/or electroencephalography (EEG) abnormalities. Table 1 summarizes the detailed phenotypes of the individuals (1-5), aged between 3 and 14 years.</text><annotation id="3034"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="5971" length="23" /><text>intellectual disability</text></annotation><annotation id="3035"><infon key="identifier">MESH:D000068079</infon><infon key="type">Disease</infon><location offset="6043" length="18" /><text>motor stereotypies</text></annotation><annotation id="3036"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="5996" length="2" /><text>ID</text></annotation><annotation id="3037"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="6130" length="17" /><text>visual impairment</text></annotation><annotation id="3038"><infon key="identifier">MESH:D009123</infon><infon key="type">Disease</infon><location offset="5937" length="9" /><text>hypotonia</text></annotation><annotation id="3039"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="6005" length="17" /><text>autistic features</text></annotation><annotation id="3040"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="6177" length="8" /><text>epilepsy</text></annotation><annotation id="3041"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="6149" length="22" /><text>hyperkinetic movements</text></annotation><annotation id="3042"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="6073" length="13" /><text>Rett syndrome</text></annotation><annotation id="3043"><infon key="identifier">MESH:D015518</infon><infon key="type">Disease</infon><location offset="6088" length="3" /><text>RTT</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6338</offset><text>In all affected children, family histories, pregnancies, and birth histories were unremarkable, and neurodevelopmental impairment occurred within the first year of life. The earliest sign of neurological involvement was axial hypotonia at birth. Poor visual fixation (with only brief and occasional visual contact, lasting up to a few seconds) had been evident since the first months of life in three affected individuals (1-3); these individuals were later diagnosed with central visual impairment (Table 1). Three children (individuals 1-3) exhibited a hyperkinetic movement disorder starting in the first year of life (Videos S1, S2, S3, and S4). Abnormal movements ranged from dystonic posturing (mainly involving the trunk, neck, and lower limbs) and moderate chorea (individuals 1 and 3) to a mixed-movement disorder with severe chorea and dystonic posturing (individual 2) or myoclonic jerks (individual 3). All children showed autistic features, typically including flapping or flailing of the arms, as well as hand wringing or clapping. Additional repetitive behavior patterns included body rocking and head banging. Self-injurious behaviors were evident in individual 2. A virtual absence of purposeful hand movements was present in all cases (Table 1, Videos S1, S2, S3, S4, and S5). Motor development in individuals 1-3 was severely impaired, and these children had not attained the ability to walk. Severe language impairment was present in the three more severely affected children (individuals 1-3), none of whom had attained meaningful speech production, but individuals 4 and 5 were capable of saying 5-10 words (Table 1).</text><annotation id="3044"><infon key="identifier">MESH:D009069</infon><infon key="type">Disease</infon><location offset="7143" length="17" /><text>movement disorder</text></annotation><annotation id="3045"><infon key="identifier">MESH:D002819</infon><infon key="type">Disease</infon><location offset="7103" length="6" /><text>chorea</text></annotation><annotation id="3046"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="7273" length="17" /><text>autistic features</text></annotation><annotation id="3047"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="6438" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3048"><infon key="identifier">MESH:D009123</infon><infon key="type">Disease</infon><location offset="6558" length="15" /><text>axial hypotonia</text></annotation><annotation id="3049"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="6819" length="17" /><text>visual impairment</text></annotation><annotation id="3050"><infon key="identifier">MESH:D012652</infon><infon key="type">Disease</infon><location offset="7464" length="14" /><text>Self-injurious</text></annotation><annotation id="3051"><infon key="identifier">MESH:D054972</infon><infon key="type">Disease</infon><location offset="7019" length="18" /><text>dystonic posturing</text></annotation><annotation id="3052"><infon key="identifier">MESH:D002819</infon><infon key="type">Disease</infon><location offset="7173" length="6" /><text>chorea</text></annotation><annotation id="3053"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="6584" length="20" /><text>Poor visual fixation</text></annotation><annotation id="3054"><infon key="identifier">MESH:D054972</infon><infon key="type">Disease</infon><location offset="7184" length="18" /><text>dystonic posturing</text></annotation><annotation id="3055"><infon key="identifier">MESH:D009207</infon><infon key="type">Disease</infon><location offset="7221" length="15" /><text>myoclonic jerks</text></annotation><annotation id="3056"><infon key="identifier">MESH:D007806</infon><infon key="type">Disease</infon><location offset="7757" length="19" /><text>language impairment</text></annotation><annotation id="3057"><infon key="identifier">MESH:D004409</infon><infon key="type">Disease</infon><location offset="6988" length="18" /><text>Abnormal movements</text></annotation><annotation id="3058"><infon key="identifier">MESH:C538190</infon><infon key="type">Disease</infon><location offset="6529" length="24" /><text>neurological involvement</text></annotation><annotation id="3059"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="6893" length="30" /><text>hyperkinetic movement disorder</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr1.jpg</infon><infon key="id">fig1</infon><infon key="type">fig_caption</infon><offset>7988</offset><text>Brain MRI Scan of Individual 1, Who Harbors a De Novo VAMP2 p.Ser75Pro Variant, at the Age of 2 Years</text><annotation id="3060"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="8042" length="5" /><text>VAMP2</text></annotation><annotation id="3061"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="8048" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr1.jpg</infon><infon key="id">fig1</infon><infon key="type">fig_caption</infon><offset>8090</offset><text>The panel shows axial T2-weighted, sagittal T1-weighted, and coronal T1-weighted MR images. There is some generalized delay in the maturation of myelin and a reduced volume of the cerebral white matter posteriorly. (Yellow arrows show a posteriorly slender corpus callosum.) The optic nerves and chiasm are hypoplastic (red arrows).</text><annotation id="3062"><infon key="identifier">MESH:D000741</infon><infon key="type">Disease</infon><location offset="8397" length="11" /><text>hypoplastic</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8423</offset><text>Seizures or abnormal EEG occurred in four affected individuals. Individual 1 did not present with epileptic seizures, but ictal EEG recording at the age of 15 months showed high-voltage delta activity with interspersed sharp-and-slow-wave complexes over the right central and posterior brain regions. Individual 2 suffered from multiple focal seizures per day; these started shortly after birth and were characterized on EEG by fast rhythmic activity followed by sharp-and-slow-wave complexes (Figure S1). At 12 months, individual 3 presented with infantile spasms that were associated with diffuse EEG paroxysms. Individual 4 developed infrequent staring episodes with eyelid myoclonia at 5 years of age and had a single episode of non-convulsive status epilepticus at the age of 11 years. Several anti-epileptic drugs, including valproic acid, vigabatrin, and lamotrigine, have been trialed in individuals 2-4 (see Supplemental Data); beneficial effects of valproic acid treatment were noted in individual 4, who has been seizure-free since the age of 12 years and has had normal follow-up EEGs. Individual 2 underwent a craniotomy for grid placement at the age of 6 months and had a right posterior circulation stroke affecting the thalamic and cortical areas; at the age of 18 months, he had a right temporal lobectomy. Brain magnetic resonance imaging (MRI) was unrevealing in all children except in individual 1, for whom mild myelination delay and a posteriorly slender corpus callosum was observed at the age of 2 years (Figure 1).</text><annotation id="3063"><infon key="identifier">MESH:D020521</infon><infon key="type">Disease</infon><location offset="9637" length="6" /><text>stroke</text></annotation><annotation id="3064"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="8423" length="8" /><text>Seizures</text></annotation><annotation id="3065"><infon key="type">Disease</infon><location offset="9100" length="9" /><text>myoclonia</text></annotation><annotation id="3066"><infon key="identifier">MESH:D003711</infon><infon key="type">Disease</infon><location offset="9856" length="17" /><text>myelination delay</text></annotation><annotation id="3067"><infon key="identifier">MESH:D020888</infon><infon key="type">Chemical</infon><location offset="9269" length="10" /><text>vigabatrin</text></annotation><annotation id="3068"><infon key="identifier">MESH:D014635</infon><infon key="type">Chemical</infon><location offset="9254" length="13" /><text>valproic acid</text></annotation><annotation id="3069"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="9222" length="4" /><text>anti</text></annotation><annotation id="3070"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="9447" length="7" /><text>seizure</text></annotation><annotation id="3071"><infon key="identifier">MESH:D000069279</infon><infon key="type">Disease</infon><location offset="9227" length="15" /><text>epileptic drugs</text></annotation><annotation id="3072"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="8521" length="18" /><text>epileptic seizures</text></annotation><annotation id="3073"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="8766" length="8" /><text>seizures</text></annotation><annotation id="3074"><infon key="identifier">MESH:D013036</infon><infon key="type">Disease</infon><location offset="8971" length="16" /><text>infantile spasms</text></annotation><annotation id="3075"><infon key="identifier">MESH:D000077213</infon><infon key="type">Chemical</infon><location offset="9285" length="11" /><text>lamotrigine</text></annotation><annotation id="3076"><infon key="identifier">MESH:D014635</infon><infon key="type">Chemical</infon><location offset="9382" length="13" /><text>valproic acid</text></annotation><annotation id="3077"><infon key="identifier">MESH:D013226</infon><infon key="type">Disease</infon><location offset="9160" length="29" /><text>convulsive status epilepticus</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9971</offset><text>The clinical features summarized above are consistent with a diagnosis of neurodevelopmental impairment with variable neurological features in all five affected individuals. Extensive initial genetic and biochemical diagnostic investigations for a range of genetic conditions, including non-syndromic ID, epileptic encephalopathies (EEs), EEs with dyskinesia, metabolic disorders, and mitochondrial diseases, were unrevealing (see Supplemental Data). Affected children were recruited for genetic analysis through the use of whole-exome sequencing (WES) at five centers. Written informed consent was obtained for all individuals and their relatives, after which DNA was extracted from peripheral lymphocytes according to standard protocols. The study was approved by the local ethics committee at University College London Hospitals (project 06/N076) and at the participating institutions. Variants of interest in VAMP2 were identified by WES of trios and confirmed by Sanger sequencing in all cases. Libraries were prepared from parents' and affected individuals' DNA, and exomes were captured and sequenced on Illumina sequencers. Raw data were processed and filtered with established pipelines and then annotated, and the Exome variant server ESP6500 was used for assessments of variant frequency in the control population (see Supplemental Data). Only exonic and donor and acceptor splicing variants were considered. Priority was given to rare variants (that had a genomic evolutionary rate profiling [GERP] score &gt;2 and were present at &lt;1% in public databases, including those of the 1000 Genomes Project, NHLBI Exome Variant Server, Complete Genomics 69, and Exome Aggregation Consortium [ExAC v0.2]). Synonymous variants were not considered. Following their respective analysis pipelines, participating centers generated a list of candidate variants filtered against variants from public databases according to modes of inheritance, then compared their results through international research networks and variant databases.</text><annotation id="3078"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="10884" length="5" /><text>VAMP2</text></annotation><annotation id="3079"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="10045" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3080"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="10331" length="19" /><text>metabolic disorders</text></annotation><annotation id="3081"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="10258" length="16" /><text>non-syndromic ID</text></annotation><annotation id="3082"><infon key="identifier">MESH:D001927</infon><infon key="type">Disease</infon><location offset="10304" length="3" /><text>EEs</text></annotation><annotation id="3083"><infon key="identifier">MESH:D001927</infon><infon key="type">Disease</infon><location offset="10310" length="3" /><text>EEs</text></annotation><annotation id="3084"><infon key="identifier">MESH:D001927</infon><infon key="type">Disease</infon><location offset="10276" length="26" /><text>epileptic encephalopathies</text></annotation><annotation id="3085"><infon key="identifier">MESH:D028361</infon><infon key="type">Disease</infon><location offset="10356" length="22" /><text>mitochondrial diseases</text></annotation><annotation id="3086"><infon key="identifier">MESH:D004409</infon><infon key="type">Disease</infon><location offset="10319" length="10" /><text>dyskinesia</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr2.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>12005</offset><text>VAMP2 Intragenic De Novo Variants Identified in This Study</text><annotation id="3087"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12005" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr2.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>12064</offset><text>(A) Individuals carrying de novo VAMP2 intragenic variants; note the hand stereotypies.</text><annotation id="3088"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12097" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr2.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>12152</offset><text>(B) Sanger sequences of five kindreds with de novo VAMP2 intragenic variants. Chromatograms of individuals 1-5 and their parents confirm the de-novo occurrence of the VAMP2 variants in all cases. M/+ denotes the indicated VAMP2 variant in the heterozygous state, and +/+ denotes homozygous wild-type sequence. Mutant bases in the probands are indicated by a red arrow.</text><annotation id="3089"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12203" length="5" /><text>VAMP2</text></annotation><annotation id="3090"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12319" length="5" /><text>VAMP2</text></annotation><annotation id="3091"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12374" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr2.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>12523</offset><text>(C) Schematic depiction of the human VAMP2 protein (GenBank: NP_055047.2) indicating the positions of the variants identified in this study.</text><annotation id="3092"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12560" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr2.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>12664</offset><text>(D) Multiple alignment showing complete conservation across species and VAMP1 homolog (GenBank: NP_055046.1) of the residues affected by the variants identified in this study (these variants are highlighted in yellow). Human VAMP2 (GenBank: NP_055047.2), chimpanzee VAMP2 (UniProt: JAA33755.1), marmoset VAMP2 (UniProt: JAB33896.1), rat VAMP2 (NP_036795.1), rabbit VAMP2 (XP_008268978.1), cow VAMP2 (GenBank: NP_776908.1), dog VAMP2 (GenBank: XP_005620068.1), zebrafish VAMP2 (GenBank: NP_956299.1).</text><annotation id="3093"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12889" length="5" /><text>VAMP2</text></annotation><annotation id="3094"><infon key="identifier">747237</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="12930" length="5" /><text>VAMP2</text></annotation><annotation id="3095"><infon key="identifier">100410194</infon><infon key="type">Gene</infon><location offset="12968" length="5" /><text>VAMP2</text></annotation><annotation id="3096"><infon key="identifier">24803</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13001" length="5" /><text>VAMP2</text></annotation><annotation id="3097"><infon key="identifier">24803</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13029" length="5" /><text>VAMP2</text></annotation><annotation id="3098"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13057" length="5" /><text>VAMP2</text></annotation><annotation id="3099"><infon key="identifier">479491</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13091" length="5" /><text>VAMP2</text></annotation><annotation id="3100"><infon key="identifier">336281</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13134" length="5" /><text>VAMP2</text></annotation><annotation id="3101"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="12736" length="5" /><text>VAMP1</text></annotation><annotation id="3102"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12883" length="5" /><text>Human</text></annotation><annotation id="3103"><infon key="identifier">7955</infon><infon key="type">Species</infon><location offset="13124" length="9" /><text>zebrafish</text></annotation><annotation id="3104"><infon key="identifier">9986</infon><infon key="type">Species</infon><location offset="13022" length="6" /><text>rabbit</text></annotation><annotation id="3105"><infon key="identifier">9615</infon><infon key="type">Species</infon><location offset="13087" length="3" /><text>dog</text></annotation><annotation id="3106"><infon key="identifier">9913</infon><infon key="type">Species</infon><location offset="13053" length="3" /><text>cow</text></annotation><annotation id="3107"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="12997" length="3" /><text>rat</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13164</offset><text>Three de novo non-synonymous variants in VAMP2 [NM_014232: c.223T&gt;C (p.Ser75Pro), c.230T&gt;C (p.Phe77Ser), c.233A&gt;C (p.Glu78Ala)] were identified in three affected individuals (1-3) recruited and studied at different centers as part of different research initiatives (see Supplemental Data). We then analyzed the genetic data from the SYNaPS Study Group collection of exomes and genomes from over 4,000 individuals affected with early-onset neurological disorders (including ~250 children with undiagnosed neurodevelopmental impairment and epilepsy) for variants in VAMP2 and identified a child (individual 4), carrying a de novo single amino acid deletion at position 43 [NM_014232: c.128_130delTGG (p.Val43del)] (Figures 2A and 2B). We next used web-based tools to screen VAMP2 variants within exome and genome datasets from established international collaborations; this process identified an additional child (individual 5) carrying a de novo single-amino-acid deletion at position 45 [GenBank: NM_014232, c.135_137delCAT (p.Ile45del)] (see Supplemental Data).</text><annotation id="3108"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13205" length="5" /><text>VAMP2</text></annotation><annotation id="3109"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13728" length="5" /><text>VAMP2</text></annotation><annotation id="3110"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="13936" length="5" /><text>VAMP2</text></annotation><annotation id="3111"><infon key="identifier">tmVar:p|DEL|43|V;HGVS:p.V43del;VariantGroup:2;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="13863" length="10" /><text>p.Val43del</text></annotation><annotation id="3112"><infon key="identifier">tmVar:c|SUB|A|233|C;HGVS:c.233A&gt;C;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">DNAMutation</infon><location offset="13269" length="8" /><text>c.233A&gt;C</text></annotation><annotation id="3113"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="13702" length="8" /><text>epilepsy</text></annotation><annotation id="3114"><infon key="identifier">tmVar:p|DEL|135_137|H;HGVS:p.H135_137del;VariantGroup:17;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="14172" length="15" /><text>c.135_137delCAT</text></annotation><annotation id="3115"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="13256" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3116"><infon key="identifier">tmVar:|DEL|43|1;HGVS:c.43del1;VariantGroup:2;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="13792" length="41" /><text>single amino acid deletion at position 43</text></annotation><annotation id="3117"><infon key="type">Species</infon><location offset="13835" length="9" /><text>NM_014232</text></annotation><annotation id="3118"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="13279" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3119"><infon key="identifier">tmVar:c|SUB|T|223|C;HGVS:c.223T&gt;C;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">DNAMutation</infon><location offset="13223" length="8" /><text>c.223T&gt;C</text></annotation><annotation id="3120"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="13233" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3121"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="13603" length="22" /><text>neurological disorders</text></annotation><annotation id="3122"><infon key="type">Species</infon><location offset="14161" length="9" /><text>NM_014232</text></annotation><annotation id="3123"><infon key="identifier">tmVar:p|DEL|45|I;HGVS:p.I45del;VariantGroup:7;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="14189" length="10" /><text>p.Ile45del</text></annotation><annotation id="3124"><infon key="identifier">tmVar:p|DEL|128_130|W;HGVS:p.W128_130del;VariantGroup:14;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="13846" length="15" /><text>c.128_130delTGG</text></annotation><annotation id="3125"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="13668" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3126"><infon key="identifier">tmVar:c|SUB|T|230|C;HGVS:c.230T&gt;C;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="13246" length="8" /><text>c.230T&gt;C</text></annotation><annotation id="3127"><infon key="identifier">tmVar:|Allele|SINGLE|45;VariantGroup:12;CorrespondingGene:6844;CorrespondingSpecies:9606</infon><infon key="type">DNAMutation</infon><location offset="14109" length="41" /><text>single-amino-acid deletion at position 45</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14232</offset><text>All the identified variants were absent from the Genome Aggregation Database and ExAC, and all displayed high conservation (mean: GERP++ 5.26) and in silico pathogenic predictor (mean: CADD_Phred 26.9) scores (see Supplemental Data). In the ExAC database (last accessed January 30, 2018), which contains exomes from 60,706 unrelated individuals, there are no listed loss-of-function variants in VAMP2, and only two non-synonymous variants (p.Asn49Lys [p.Val50Met]) are present within the SNARE motif (amino acids 31-91).</text><annotation id="3128"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="14627" length="5" /><text>VAMP2</text></annotation><annotation id="3129"><infon key="identifier">tmVar:p|SUB|V|50|M;HGVS:p.V50M;VariantGroup:5;OriginalGene:336281;CorrespondingGene:6844;RS#:781008796;CorrespondingSpecies:7955</infon><infon key="type">ProteinMutation</infon><location offset="14684" length="10" /><text>p.Val50Met</text></annotation><annotation id="3130"><infon key="identifier">tmVar:p|SUB|N|49|K;HGVS:p.N49K;VariantGroup:3;OriginalGene:336281;CorrespondingGene:6844;RS#:376454310;CorrespondingSpecies:7955</infon><infon key="type">ProteinMutation</infon><location offset="14672" length="10" /><text>p.Asn49Lys</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr3.jpg</infon><infon key="id">fig3</infon><infon key="type">fig_caption</infon><offset>14755</offset><text>Molecular Modeling of the Identified De Novo VAMP2 Non-Synonymous Variants</text><annotation id="3131"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="14800" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr3.jpg</infon><infon key="id">fig3</infon><infon key="type">fig_caption</infon><offset>14830</offset><text>Comparison between the p.Ser75Pro (A), p.Phe77Ser (B), and p.Glu78Ala (C) mutant conformation within the SNARE complex (left panel, red square). The wild-type conformation is shown in the middle panel, and the mutated residues are shown in the right panel. Variant p.Ser75Pro causes the loss of two hydrogen bonds, one interchain between Ser75 of VAMP2 and Tyr243 of STX1A and one intrachain between Ser75 and Gln71; variant p.Phe77Ser introduces a hydrophilic residue in an otherwise hydrophobic region; and variant p.Glu78Ala causes the loss of a hydrogen bond between Glu78 of VAMP2 and Arg246 of STX1A. Modeling of the VAMP2 ectodomain (green for WT, light green for mutants) in complex with STX1A (orange for WT, light orange for mutants) and Snap25 (blue and cyan for WT, marine and aquamarine for mutants); configurations are as seen 100 ns into the molecular dynamic simulation. The complexes were modeled from the humanized 3HD7 complex. Water molecules and ions are not shown.</text><annotation id="3132"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="15177" length="5" /><text>VAMP2</text></annotation><annotation id="3133"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="15197" length="5" /><text>STX1A</text></annotation><annotation id="3134"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="15410" length="5" /><text>VAMP2</text></annotation><annotation id="3135"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="15430" length="6" /><text>STX1A.</text></annotation><annotation id="3136"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="15453" length="5" /><text>VAMP2</text></annotation><annotation id="3137"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="15526" length="5" /><text>STX1A</text></annotation><annotation id="3138"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="15578" length="6" /><text>Snap25</text></annotation><annotation id="3139"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="14889" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3140"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="15619" length="10" /><text>aquamarine</text></annotation><annotation id="3141"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="15095" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3142"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="14853" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3143"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="15255" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3144"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="15763" length="4" /><text>3HD7</text></annotation><annotation id="3145"><infon key="identifier">tmVar:p|Allele|E|78;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="15401" length="5" /><text>Glu78</text></annotation><annotation id="3146"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="14869" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3147"><infon key="identifier">tmVar:p|Allele|S|75;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="15230" length="5" /><text>Ser75</text></annotation><annotation id="3148"><infon key="identifier">MESH:D014867</infon><infon key="type">Chemical</infon><location offset="15777" length="5" /><text>Water</text></annotation><annotation id="3149"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="15347" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3150"><infon key="identifier">tmVar:p|Allele|S|75;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="15168" length="5" /><text>Ser75</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>15820</offset><text>The de novo non-synonymous variants identified in this study cluster in close proximity within the C-terminal portion of the SNARE motif (Figure 2C). Interspecies alignment of protein sequences generated with Clustal Omega show that all mutations occur within the SNARE motif at residues highly conserved through evolution (Figure 2D). Figure 3 shows positions of the mutated amino acids within a 3D structure of the VAMP2 ectodomain in complex with STX1A and SNAP25. Replacement analysis shows that the p.Ser75Pro variant will result in the loss of two hydrogen bonds, one interchain between Ser75 of VAMP2 and Tyr243 of STX1A and one intrachain between Ser75 and Gln71, although the p.Phe77Ser variant introduces a hydrophilic residue in an otherwise hydrophobic region and the p.Glu78Ala variant disrupts the hydrogen bond between Glu78 of VAMP2 and Arg246 of STX1A.</text><annotation id="3151"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="16237" length="5" /><text>VAMP2</text></annotation><annotation id="3152"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="16270" length="5" /><text>STX1A</text></annotation><annotation id="3153"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="16280" length="6" /><text>SNAP25</text></annotation><annotation id="3154"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="16422" length="5" /><text>VAMP2</text></annotation><annotation id="3155"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="16442" length="5" /><text>STX1A</text></annotation><annotation id="3156"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="16663" length="5" /><text>VAMP2</text></annotation><annotation id="3157"><infon key="identifier">6804</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37941</infon><location offset="16683" length="5" /><text>STX1A</text></annotation><annotation id="3158"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="16505" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3159"><infon key="identifier">tmVar:p|Allele|S|75;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16475" length="5" /><text>Ser75</text></annotation><annotation id="3160"><infon key="identifier">tmVar:p|Allele|E|78;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16654" length="5" /><text>Glu78</text></annotation><annotation id="3161"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16324" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3162"><infon key="identifier">tmVar:p|Allele|S|75;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16413" length="5" /><text>Ser75</text></annotation><annotation id="3163"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16600" length="10" /><text>p.Glu78Ala</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>16693</offset><text>To determine whether these disease-associated variants affect VAMP2 structure and SNARE complex stability, we performed 100 ns molecular dynamics (MD) simulations by using a humanized version of the neuronal SNARE complex (PDB 3HD7, see Supplemental Data). During the simulations, the WT and p.Ser75Pro seemed to reach a stationary state, but major rearrangements were still observed for p.Phe77Ser and p.Glu78Ala at the end of the simulation. This was evident in their backbone root-mean-square deviation (RMSD) and radius of gyration, which measure the divergence of the mutant protein structure from its initial structure over the course of the simulation. In all cases, the most mobile portion of the chain was that close to the C terminus, as seen in their root mean squared fluctuation (RMSF). The RMSF further indicates that in all cases, the variants increase the mobility of the backbone, and this effect is particularly evident for p.Glu78Ala. Overall rearrangements of the complex are shown in Figures S2-S3.</text><annotation id="3164"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="16755" length="5" /><text>VAMP2</text></annotation><annotation id="3165"><infon key="identifier">CVCL:Z232</infon><infon key="type">CellLine</infon><location offset="17706" length="2" /><text>S2</text></annotation><annotation id="3166"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="17096" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3167"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="17635" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3168"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="17081" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3169"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="16985" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>17716</offset><text>To examine VAMP2 expression across CNS regions, we used microarray data (Affymetrix Exon 1.0 ST) from human post-mortem brain tissues as previously described. This analysis showed the highest VAMP2 expression in the putamen and the frontal lobes (Figure S4).</text><annotation id="3170"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="17727" length="5" /><text>VAMP2</text></annotation><annotation id="3171"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="17908" length="5" /><text>VAMP2</text></annotation><annotation id="3172"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="17818" length="5" /><text>human</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>17976</offset><text>Disease-Associated VAMP2 Variants Result in Reduced Fusion Rates</text><annotation id="3173"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="17995" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18041</offset><text>(A) Scheme showing the liposome fusion assay.</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18087</offset><text>(B) The SDS-PAGE and Coomassie-stained gel image of VAMP2 WT, VAMP2 disease-associated variants (p.Ser75Pro [p.Glu78Ala]), and t-SNARE (syntaxin 1 and SNAP25) reconstitution into donor v- and acceptor t-liposomes, respectively.</text><annotation id="3174"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="18149" length="5" /><text>VAMP2</text></annotation><annotation id="3175"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="18139" length="5" /><text>VAMP2</text></annotation><annotation id="3176"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="18238" length="6" /><text>SNAP25</text></annotation><annotation id="3177"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="18196" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3178"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="18184" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18315</offset><text>(C) Line graphs showing the average basal (without Munc18-1) increase that occurs in NBD fluorescence as a result of fusion between the v-liposome and t-SNARE liposomes carrying WT or VAMP2 disease variants (p.Ser75Pro [p.Glu78Ala]). Liposome fusion reaction in the presence of CDV was used as negative control.</text><annotation id="3179"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="18499" length="5" /><text>VAMP2</text></annotation><annotation id="3180"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="18366" length="8" /><text>Munc18-1</text></annotation><annotation id="3181"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="18535" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3182"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="18523" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3183"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="18593" length="3" /><text>CDV</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18627</offset><text>(D) Basal fusion quantification, normalized to WT, at the endpoint (60 min) as described in (C).</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18725</offset><text>(E) Line graphs of liposome fusion reaction as in (C), in the presence of 5 muM Munc18-1.</text><annotation id="3184"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="18805" length="8" /><text>Munc18-1</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">gr4.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>18816</offset><text>(F) Endpoint fusion quantification, normalized to WT, (60 min) of experiment as described in (E). Bar graphs also showed endpoint quantification of a similar experiment that used a v-liposome that contained a mixture of WT and mutant VAMP2 proteins. Data were from at least four independent replicates and presented as means plus SD. *p &lt; 0.05; ** p &lt; 0.01; *** p &lt; 0.001; n.s., not significant (p &gt; 0.05).</text><annotation id="3185"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="19050" length="5" /><text>VAMP2</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>19236</offset><text>To evaluate the functional consequence of VAMP2 variants, we employed the reconstituted, lipid-mixing assay based on NBD (N-[7-nitro-2-1, 3-benzoxadiazol-4-yl])-to-RHO (lissamine rhodamine B) energy transfer (see Supplemental Data). In this assay, the VAMP2 (wild-type [WT] or mutant) was included in the fluorescent donor liposomes, whereas the t-SNAREs were reconstituted into the non-fluorescent acceptor liposomes. We read out membrane fusion between the donor and acceptor liposome mixing by quantifying increased fluorescence resulting from the dequenching of NBD fluorescence (Figure 4A). To this end, we purified WT VAMP2 and the variant protein along with the t-SNARE complex by using a bacterial expression system as previously described. We were able to purify the p.Ser75Pro and p.Glu78Ala variants, and Coomassie-stained SDS-PAGE analysis showed that these variants were structurally intact and highly pure with no contamination (Figure S5). However, all attempts to isolate the p.Phe77Ser were unsuccessful. We therefore limited our in vitro fusion analysis to the two remaining non-synonymous variants (p.Ser75Pro and p.Glu78Ala).</text><annotation id="3186"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="19278" length="5" /><text>VAMP2</text></annotation><annotation id="3187"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="19488" length="5" /><text>VAMP2</text></annotation><annotation id="3188"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="19860" length="5" /><text>VAMP2</text></annotation><annotation id="3189"><infon key="identifier">MESH:D012967</infon><infon key="type">Chemical</infon><location offset="20070" length="3" /><text>SDS</text></annotation><annotation id="3190"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19802" length="3" /><text>NBD</text></annotation><annotation id="3191"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19353" length="3" /><text>NBD</text></annotation><annotation id="3192"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="20052" length="9" /><text>Coomassie</text></annotation><annotation id="3193"><infon key="identifier">MESH:C022027</infon><infon key="type">Chemical</infon><location offset="19405" length="21" /><text>lissamine rhodamine B</text></annotation><annotation id="3194"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19358" length="39" /><text>N-[7-nitro-2-1, 3-benzoxadiazol-4-yl])-</text></annotation><annotation id="3195"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20012" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3196"><infon key="identifier">tmVar:p|SUB|F|77|S;HGVS:p.F77S;VariantGroup:1;CorrespondingGene:6857;RS#:755159855;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="20228" length="10" /><text>p.Phe77Ser</text></annotation><annotation id="3197"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20369" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3198"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="19325" length="5" /><text>lipid</text></annotation><annotation id="3199"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20354" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3200"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20027" length="10" /><text>p.Glu78Ala</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>20385</offset><text>As shown in Figures 4C-4F, the VAMP2 disease-associated variant p.Ser75Pro reduced the rate and extent of fusion compared to that seen with VAMP2 WT, whereas the p.Glu78Ala variant had little to no effect (Figures 4C and 4D). The reduction in the fusion associated with p.Ser75Pro was estimated to be approximately 25% that in the WT, suggesting that the introduction of a proline residue at this site most likely interferes with the proper assembly of the SNARE proteins and thus affects VAMP2 fusion properties, whereas the fusion profile associated with the p.Glu78Ala was indistinguishable from that of the WT.</text><annotation id="3201"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="20416" length="5" /><text>VAMP2</text></annotation><annotation id="3202"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="20525" length="5" /><text>VAMP2</text></annotation><annotation id="3203"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="20874" length="5" /><text>VAMP2</text></annotation><annotation id="3204"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20946" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3205"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20547" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3206"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20655" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3207"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="20449" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>21002</offset><text>Earlier studies have shown that Munc18 chaperones SNARE assembly via interactions with the VAMP2 C-terminal region. We therefore investigated the effect of the disease variants under Munc18-activated conditions. As expected, inclusion of Munc18-1 produced an approximately 2-fold increase in the rate and extent of fusion when WT VAMP2 was used (Figure 4E). Strikingly, Munc18 could not activate the fusion mediated by the VAMP2 p.Ser75Pro variant (Figure 4E). Consequently, we observed a significant (&gt;90%) loss-of-function phenotype with the p.Ser75Pro variant under these conditions. In contrast, Munc18 was able to activate the fusion mediated by VAMP2 p.Glu78Ala, confirming that this variant does not affect the SNARE assembly process or its activation. To accurately emulate the physiological make-up of the individuals carrying heterozygous de novo VAMP2 variants, we also tested the effect of replacing half the copies of WT VAMP2 with the disease variants (Figure S4). Remarkably, in the case of p.Ser75Pro, the fusion profile for the mixed v-liposomes (50:50 WT:mutant) was identical to the fusion profile for the homogenous samples containing only the mutant proteins (Figure 4F; Figure S4). This implies that p.Ser75Pro mutant dominantly interferes with WT (Figure 4F), and this could readily explain the pathological phenotype observed with this variant.</text><annotation id="3208"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21093" length="5" /><text>VAMP2</text></annotation><annotation id="3209"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="21240" length="8" /><text>Munc18-1</text></annotation><annotation id="3210"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21332" length="5" /><text>VAMP2</text></annotation><annotation id="3211"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21425" length="5" /><text>VAMP2</text></annotation><annotation id="3212"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21653" length="5" /><text>VAMP2</text></annotation><annotation id="3213"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21859" length="5" /><text>VAMP2</text></annotation><annotation id="3214"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="21936" length="5" /><text>VAMP2</text></annotation><annotation id="3215"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="21431" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3216"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="22224" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3217"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="21659" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3218"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="22008" length="10" /><text>p.Ser75Pro</text></annotation><annotation id="3219"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="21546" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>22377</offset><text>Our genetic and functional studies show that de novo mutations in VAMP2 cause neurodevelopmental impairment associated with variable clinical features. Individuals 1-3, carrying de novo non-synonymous variants affecting the C terminus of the VAMP2 SNARE motif (residues 75, 77, and 78), presented a severe neurological phenotype with motor impairment (and inability to walk), central visual deficits, hyperkinetic movements, and, in two of them, epilepsy starting in infancy. Individuals 4 and 5, carrying de novo single-amino-acid deletions involving residues at positions 43 and 45, presented a less severe neurological involvement, acquired the ability to walk, and were able to pronounce a few words. MD simulations showed that missense mutations in the C terminus induce higher flexibility of this region within the assembled SNARE complexes. The in vitro lipid-mixing assay revealed a significant defect in vesicle fusion as a consequence of the p.Ser75Pro variant, but p.Glu78Ala had no clear functional consequence. The pathophysiological phenotype for the p.Glu78Ala variant might be due to impaired interactions with regulatory proteins that were not included in the in vitro assay. Notably, the assembly of the C-terminal region of the SNARE proteins is considered critical to driving membrane fusion, and several synaptic regulatory proteins modulate vesicle fusion by binding the C-terminal portion of the SNARE complex. Thus, mutations affecting this region could disturb the SNARE complex assembly by less-efficient partnering of cognate SNARE proteins and/or disrupt its association with regulatory elements such as Munc18-1 or Synaptotagmin. In the physiological context, this would manifest as the perturbation of Ca2+-triggered neurotransmitter release. Even a slight alteration of the fusion kinetics in vitro would translate to a dramatic effect on the release of neurotransmitters release at the neuronal synapses. This might explain the severe neurodevelopmental impairment observed in the VAMP2 synaptopathy. Interestingly, variants affecting the Ser75 residue have previously been shown to impair the Munc18-1 stimulatory activity by impairing its ability to regulate trans-SNARE zippering, and variants involving residue Glu78 can also affect Ca2+-regulated neurotransmitter release.</text><annotation id="3220"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="22443" length="5" /><text>VAMP2</text></annotation><annotation id="3221"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="22619" length="5" /><text>VAMP2</text></annotation><annotation id="3222"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="24009" length="8" /><text>Munc18-1</text></annotation><annotation id="3223"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="24390" length="5" /><text>VAMP2</text></annotation><annotation id="3224"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="24503" length="8" /><text>Munc18-1</text></annotation><annotation id="3225"><infon key="identifier">MESH:C538190</infon><infon key="type">Disease</infon><location offset="22986" length="24" /><text>neurological involvement</text></annotation><annotation id="3226"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="24344" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3227"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="24109" length="4" /><text>Ca2+</text></annotation><annotation id="3228"><infon key="identifier">MESH:D014786</infon><infon key="type">Disease</infon><location offset="22761" length="15" /><text>visual deficits</text></annotation><annotation id="3229"><infon key="identifier">tmVar:p|Allele|S|75;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="24448" length="5" /><text>Ser75</text></annotation><annotation id="3230"><infon key="identifier">tmVar:p|Allele|E|78;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="24624" length="5" /><text>Glu78</text></annotation><annotation id="3231"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="22455" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3232"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="22823" length="8" /><text>epilepsy</text></annotation><annotation id="3233"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="23442" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3234"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="22683" length="22" /><text>neurological phenotype</text></annotation><annotation id="3235"><infon key="type">Disease</infon><location offset="24396" length="12" /><text>synaptopathy</text></annotation><annotation id="3236"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="24646" length="4" /><text>Ca2+</text></annotation><annotation id="3237"><infon key="identifier">MESH:D000068079</infon><infon key="type">Disease</infon><location offset="22711" length="16" /><text>motor impairment</text></annotation><annotation id="3238"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="22778" length="22" /><text>hyperkinetic movements</text></annotation><annotation id="3239"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="23238" length="5" /><text>lipid</text></annotation><annotation id="3240"><infon key="identifier">tmVar:p|SUB|E|78|A;HGVS:p.E78A;VariantGroup:4;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="23353" length="10" /><text>p.Glu78Ala</text></annotation><annotation id="3241"><infon key="identifier">tmVar:p|SUB|S|75|P;HGVS:p.S75P;VariantGroup:0;OriginalGene:282116;CorrespondingGene:6844;CorrespondingSpecies:9913</infon><infon key="type">ProteinMutation</infon><location offset="23329" length="10" /><text>p.Ser75Pro</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>24692</offset><text>1. variants in SNAP25 (MIM: 60322) isoforms SNAP25a and SNAP25b; these variants have been identified in association with ID, seizures, and myasthenia</text><annotation id="3242"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="24707" length="6" /><text>SNAP25</text></annotation><annotation id="3243"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="24817" length="8" /><text>seizures</text></annotation><annotation id="3244"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="24813" length="2" /><text>ID</text></annotation><annotation id="3245"><infon key="identifier">MESH:D020294</infon><infon key="type">Disease</infon><location offset="24831" length="10" /><text>myasthenia</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>24842</offset><text>2. variants in SYT1 (MIM: 185605), which encodes the Ca2+-sensor synaptotagmin-1 required for evoked synchronous fusion; these variants are found in individuals with NDDs and hyperkinetic movements</text><annotation id="3246"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="24857" length="4" /><text>SYT1</text></annotation><annotation id="3247"><infon key="identifier">760</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">37256</infon><location offset="24895" length="5" /><text>Ca2+-</text></annotation><annotation id="3248"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="24907" length="15" /><text>synaptotagmin-1</text></annotation><annotation id="3249"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25008" length="4" /><text>NDDs</text></annotation><annotation id="3250"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="25017" length="22" /><text>hyperkinetic movements</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25041</offset><text>3. variants in genes encoding the RIM interactor PNKD or the SNAP25 and synaptotagmin-1 interactor PRRT2; these variants have been identified in different forms of dyskinesias and seizures (MIM: 128200; MIM: 60575)</text><annotation id="3251"><infon key="identifier">22999</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">128399</infon><location offset="25075" length="3" /><text>RIM</text></annotation><annotation id="3252"><infon key="identifier">25953</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">75045</infon><location offset="25090" length="4" /><text>PNKD</text></annotation><annotation id="3253"><infon key="identifier">6616</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">13311</infon><location offset="25102" length="6" /><text>SNAP25</text></annotation><annotation id="3254"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="25113" length="15" /><text>synaptotagmin-1</text></annotation><annotation id="3255"><infon key="identifier">112476</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">114328</infon><location offset="25140" length="5" /><text>PRRT2</text></annotation><annotation id="3256"><infon key="identifier">MESH:D004409</infon><infon key="type">Disease</infon><location offset="25205" length="24" /><text>dyskinesias and seizures</text></annotation><annotation id="3257"><infon key="type">Disease</infon><location offset="25244" length="3" /><text>MIM</text></annotation><annotation id="3258"><infon key="type">Disease</infon><location offset="25231" length="3" /><text>MIM</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25256</offset><text>4. variants in UNC13A (MIM: 609894), encoding the synaptic regulator Munc13-1; these variants have been linked to an NDD with involuntary movements</text><annotation id="3259"><infon key="identifier">23025</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11279</infon><location offset="25271" length="6" /><text>UNC13A</text></annotation><annotation id="3260"><infon key="identifier">23025</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11279</infon><location offset="25325" length="8" /><text>Munc13-1</text></annotation><annotation id="3261"><infon key="type">Disease</infon><location offset="25373" length="3" /><text>NDD</text></annotation><annotation id="3262"><infon key="identifier">MESH:D020820</infon><infon key="type">Disease</infon><location offset="25382" length="21" /><text>involuntary movements</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25404</offset><text>5. variants in STXBP1 (MIM: 602926), encoding Munc18-1; these variants cause NDDs with epilepsy and autistic features</text><annotation id="3263"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="25419" length="6" /><text>STXBP1</text></annotation><annotation id="3264"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="25450" length="8" /><text>Munc18-1</text></annotation><annotation id="3265"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="25491" length="8" /><text>epilepsy</text></annotation><annotation id="3266"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25481" length="4" /><text>NDDs</text></annotation><annotation id="3267"><infon key="identifier">MESH:D001321</infon><infon key="type">Disease</infon><location offset="25504" length="17" /><text>autistic features</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25522</offset><text>The present work adds to the evidence that neurodevelopmental disorders (NDDs) have a strong genetic component and encompass a range of frequently co-existing conditions, including ID, developmental delay (DD), and autism spectrum disorders (ASDs). Neurodevelopmental impairment, epilepsy, and movement disorders also frequently co-exist. Rare variants in genes that encode a number of presynaptic proteins involved in Ca2+-regulated neurotransmitter release have been identified in individuals affected by a spectrum of neurological disorders. These include the following:</text><annotation id="3268"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25728" length="2" /><text>DD</text></annotation><annotation id="3269"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25595" length="4" /><text>NDDs</text></annotation><annotation id="3270"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="25771" length="29" /><text>Neurodevelopmental impairment</text></annotation><annotation id="3271"><infon key="identifier">MESH:D000067877</infon><infon key="type">Disease</infon><location offset="25737" length="25" /><text>autism spectrum disorders</text></annotation><annotation id="3272"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25941" length="4" /><text>Ca2+</text></annotation><annotation id="3273"><infon key="identifier">MESH:D000067877</infon><infon key="type">Disease</infon><location offset="25764" length="4" /><text>ASDs</text></annotation><annotation id="3274"><infon key="identifier">MESH:D009069</infon><infon key="type">Disease</infon><location offset="25816" length="18" /><text>movement disorders</text></annotation><annotation id="3275"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="25802" length="8" /><text>epilepsy</text></annotation><annotation id="3276"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25565" length="28" /><text>neurodevelopmental disorders</text></annotation><annotation id="3277"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="26043" length="22" /><text>neurological disorders</text></annotation><annotation id="3278"><infon key="identifier">MESH:D008607</infon><infon key="type">Disease</infon><location offset="25703" length="2" /><text>ID</text></annotation><annotation id="3279"><infon key="identifier">MESH:D002658</infon><infon key="type">Disease</infon><location offset="25707" length="19" /><text>developmental delay</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>26096</offset><text>The phenotypes associated with the VAMP2 synaptopathy reported here are reminiscent of the variability reported in some individuals who have de-novo variants in STXBP1 or in SYT1 and who can present with a combination of neurodevelopmental impairment, stereotypies, hyperkinetic movements (including chorea and dystonia), and EEG anomalies or epileptic syndromes of variable severity.</text><annotation id="3280"><infon key="identifier">282116</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="26131" length="5" /><text>VAMP2</text></annotation><annotation id="3281"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="26257" length="6" /><text>STXBP1</text></annotation><annotation id="3282"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="26270" length="4" /><text>SYT1</text></annotation><annotation id="3283"><infon key="identifier">MESH:D004421</infon><infon key="type">Disease</infon><location offset="26407" length="8" /><text>dystonia</text></annotation><annotation id="3284"><infon key="identifier">MESH:D000073376</infon><infon key="type">Disease</infon><location offset="26439" length="19" /><text>epileptic syndromes</text></annotation><annotation id="3285"><infon key="identifier">MESH:D002819</infon><infon key="type">Disease</infon><location offset="26396" length="6" /><text>chorea</text></annotation><annotation id="3286"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="26362" length="22" /><text>hyperkinetic movements</text></annotation><annotation id="3287"><infon key="type">Disease</infon><location offset="26137" length="12" /><text>synaptopathy</text></annotation><annotation id="3288"><infon key="type">Disease</infon><location offset="26348" length="12" /><text>stereotypies</text></annotation><annotation id="3289"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="26317" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3290"><infon key="identifier">MESH:D000013</infon><infon key="type">Disease</infon><location offset="26426" length="9" /><text>anomalies</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>26481</offset><text>Notably, a heterozygous mutation in a synaptobrevin homolog, VAMP1, which encodes a protein involved in vesicle fusion mainly at neuromuscular synapses, has been linked to spastic ataxia in families from Newfoundland. More recently, biallelic mutations in VAMP1 have been identified in association with a phenotype of congenital hypotonia and muscle weakness, and in three of these families neurophysiological evidence of presynaptic neuromuscular transmission impairment was detected and led to a diagnosis of presynaptic congenital myasthenic syndrome.</text><annotation id="3291"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="26542" length="5" /><text>VAMP1</text></annotation><annotation id="3292"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="26737" length="5" /><text>VAMP1</text></annotation><annotation id="3293"><infon key="identifier">MESH:D009123</infon><infon key="type">Disease</infon><location offset="26799" length="20" /><text>congenital hypotonia</text></annotation><annotation id="3294"><infon key="identifier">MESH:D020294</infon><infon key="type">Disease</infon><location offset="27004" length="30" /><text>congenital myasthenic syndrome</text></annotation><annotation id="3295"><infon key="identifier">MESH:D020511</infon><infon key="type">Disease</infon><location offset="26915" length="37" /><text>neuromuscular transmission impairment</text></annotation><annotation id="3296"><infon key="identifier">MESH:D018908</infon><infon key="type">Disease</infon><location offset="26824" length="15" /><text>muscle weakness</text></annotation><annotation id="3297"><infon key="identifier">MESH:C564815</infon><infon key="type">Disease</infon><location offset="26653" length="14" /><text>spastic ataxia</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>27036</offset><text>In conclusion, we have identified a neurodevelopmental disease that is variably associated with additional neurological features, including epilepsy and hyperkinetic movements, and that is caused by de novo mutations in VAMP2. These results further delineate an emerging spectrum of human core synaptopathies caused by variants in genes that encode SNAREs and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired presynaptic neurotransmission at nerve terminals; this impaired neurotransmission results in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by VAMP2 mutations highlights the key roles of this gene in human brain development and function. Variability in the effects of different VAMP2 mutants under in vitro conditions points toward mutation-specific mechanisms underlying the presynaptic defect of the affected children, and this variability highlights a promising area of future research.</text><annotation id="3298"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="27256" length="5" /><text>VAMP2</text></annotation><annotation id="3299"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="27767" length="5" /><text>VAMP2</text></annotation><annotation id="3300"><infon key="identifier">6844</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">7591</infon><location offset="27902" length="5" /><text>VAMP2</text></annotation><annotation id="3301"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27824" length="5" /><text>human</text></annotation><annotation id="3302"><infon key="identifier">MESH:D009422</infon><infon key="type">Disease</infon><location offset="27657" length="29" /><text>neurodevelopmental impairment</text></annotation><annotation id="3303"><infon key="identifier">MESH:D004409</infon><infon key="type">Disease</infon><location offset="27712" length="18" /><text>abnormal movements</text></annotation><annotation id="3304"><infon key="identifier">MESH:D006948</infon><infon key="type">Disease</infon><location offset="27189" length="22" /><text>hyperkinetic movements</text></annotation><annotation id="3305"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27319" length="5" /><text>human</text></annotation><annotation id="3306"><infon key="identifier">MESH:D012640</infon><infon key="type">Disease</infon><location offset="27698" length="8" /><text>seizures</text></annotation><annotation id="3307"><infon key="identifier">MESH:D004827</infon><infon key="type">Disease</infon><location offset="27176" length="8" /><text>epilepsy</text></annotation><annotation id="3308"><infon key="identifier">MESH:D018908</infon><infon key="type">Disease</infon><location offset="27688" length="8" /><text>weakness</text></annotation><annotation id="3309"><infon key="identifier">MESH:D004194</infon><infon key="type">Disease</infon><location offset="27072" length="26" /><text>neurodevelopmental disease</text></annotation><annotation id="3310"><infon key="type">Disease</infon><location offset="27330" length="14" /><text>synaptopathies</text></annotation><annotation id="3311"><infon key="type">Disease</infon><location offset="27744" length="12" /><text>synaptopathy</text></annotation></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>28115</offset><text>Declaration of Interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>28140</offset><text>The authors declare no competing interests.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>28184</offset><text>References</text></passage><passage><infon key="volume">490</infon><infon key="name_1">surname:Fasshauer;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Jahn;given-names:R.</infon><infon key="fpage">201</infon><infon key="pub-id_pmid">23060190</infon><infon key="year">2012</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">207</infon><offset>28195</offset><text>Molecular machines governing exocytosis of synaptic vesicles</text></passage><passage><infon key="name_3">surname:Sollner;given-names:T.H.</infon><infon key="name_2">surname:Melia;given-names:T.J.</infon><infon key="name_1">surname:Ahmed;given-names:M.</infon><infon key="name_0">surname:Hu;given-names:C.</infon><infon key="fpage">1745</infon><infon key="pub-id_pmid">12805548</infon><infon key="year">2003</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">300</infon><infon key="section_type">REF</infon><infon key="lpage">1749</infon><infon key="name_5">surname:Rothman;given-names:J.E.</infon><infon key="name_4">surname:Mayer;given-names:T.</infon><offset>28256</offset><text>Fusion of cells by flipped SNAREs</text></passage><passage><infon key="name_3">surname:Doung;given-names:Y.C.</infon><infon key="name_2">surname:Patel;given-names:S.M.</infon><infon key="name_1">surname:Scales;given-names:S.J.</infon><infon key="name_0">surname:Chen;given-names:Y.A.</infon><infon key="fpage">165</infon><infon key="pub-id_pmid">10219238</infon><infon key="year">1999</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="section_type">REF</infon><infon key="lpage">174</infon><infon key="name_4">surname:Scheller;given-names:R.H.</infon><offset>28290</offset><text>SNARE complex formation is triggered by Ca2+ and drives membrane fusion</text></passage><passage><infon key="name_3">surname:Reinisch;given-names:K.M.</infon><infon key="name_2">surname:Coleman;given-names:J.</infon><infon key="name_1">surname:Kummel;given-names:D.</infon><infon key="name_0">surname:Li;given-names:F.</infon><infon key="fpage">3456</infon><infon key="pub-id_pmid">24533674</infon><infon key="year">2014</infon><infon key="source">J. Am. Chem. Soc.</infon><infon key="type">ref</infon><infon key="volume">136</infon><infon key="section_type">REF</infon><infon key="lpage">3464</infon><infon key="name_5">surname:Pincet;given-names:F.</infon><infon key="name_4">surname:Rothman;given-names:J.E.</infon><offset>28362</offset><text>A half-zippered SNARE complex represents a functional intermediate in membrane fusion</text></passage><passage><infon key="name_3">surname:Xi;given-names:Z.</infon><infon key="name_2">surname:Gundersen;given-names:G.</infon><infon key="name_1">surname:Zorman;given-names:S.</infon><infon key="name_0">surname:Gao;given-names:Y.</infon><infon key="fpage">1340</infon><infon key="pub-id_pmid">22903523</infon><infon key="year">2012</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">337</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Zhang;given-names:Y.</infon><infon key="lpage">1343</infon><infon key="name_6">surname:Rothman;given-names:J.E.</infon><infon key="name_5">surname:Sirinakis;given-names:G.</infon><infon key="name_4">surname:Ma;given-names:L.</infon><offset>28448</offset><text>Single reconstituted neuronal SNARE complexes zipper in three distinct stages</text></passage><passage><infon key="volume">276</infon><infon key="name_1">surname:Sollner;given-names:T.H.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Rothman;given-names:J.E.</infon><infon key="fpage">1212</infon><infon key="pub-id_pmid">9182331</infon><infon key="year">1997</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="lpage">1213</infon><offset>28526</offset><text>Throttles and dampers: controlling the engine of membrane fusion</text></passage><passage><infon key="name_3">surname:Westermann;given-names:B.</infon><infon key="name_2">surname:McNew;given-names:J.A.</infon><infon key="name_1">surname:Zemelman;given-names:B.V.</infon><infon key="name_0">surname:Weber;given-names:T.</infon><infon key="fpage">759</infon><infon key="pub-id_pmid">9529252</infon><infon key="year">1998</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Rothman;given-names:J.E.</infon><infon key="lpage">772</infon><infon key="name_6">surname:Sollner;given-names:T.H.</infon><infon key="name_5">surname:Parlati;given-names:F.</infon><infon key="name_4">surname:Gmachl;given-names:M.</infon><offset>28591</offset><text>SNAREpins: minimal machinery for membrane fusion</text></passage><passage><infon key="name_3">surname:Fisher;given-names:L.E.</infon><infon key="name_2">surname:McNew;given-names:J.A.</infon><infon key="name_1">surname:Weber;given-names:T.</infon><infon key="name_0">surname:Melia;given-names:T.J.</infon><infon key="fpage">929</infon><infon key="pub-id_pmid">12213837</infon><infon key="year">2002</infon><infon key="source">J. Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">158</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Rothman;given-names:J.E.</infon><infon key="name_7">surname:Sollner;given-names:T.H.</infon><infon key="lpage">940</infon><infon key="name_6">surname:Mahal;given-names:L.K.</infon><infon key="name_5">surname:Parlati;given-names:F.</infon><infon key="name_4">surname:Johnston;given-names:R.J.</infon><offset>28640</offset><text>Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins</text></passage><passage><infon key="volume">38</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Brunger;given-names:A.T.</infon><infon key="fpage">1</infon><infon key="pub-id_pmid">16336742</infon><infon key="year">2005</infon><infon key="source">Q. Rev. Biophys.</infon><infon key="type">ref</infon><infon key="lpage">47</infon><offset>28745</offset><text>Structure and function of SNARE and SNARE-interacting proteins</text></passage><passage><infon key="volume">15</infon><infon key="name_1">surname:Rosenmund;given-names:C.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Rizo;given-names:J.</infon><infon key="fpage">665</infon><infon key="pub-id_pmid">18618940</infon><infon key="year">2008</infon><infon key="source">Nat. Struct. Mol. Biol.</infon><infon key="type">ref</infon><infon key="lpage">674</infon><offset>28808</offset><text>Synaptic vesicle fusion</text></passage><passage><infon key="name_3">surname:Riedel;given-names:D.</infon><infon key="name_2">surname:Behrmann;given-names:E.</infon><infon key="name_1">surname:Stein;given-names:A.</infon><infon key="name_0">surname:Hernandez;given-names:J.M.</infon><infon key="fpage">1581</infon><infon key="pub-id_pmid">22653732</infon><infon key="year">2012</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">336</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Jahn;given-names:R.</infon><infon key="name_7">surname:Raunser;given-names:S.</infon><infon key="lpage">1584</infon><infon key="name_6">surname:Walla;given-names:P.J.</infon><infon key="name_5">surname:Farsi;given-names:Z.</infon><infon key="name_4">surname:Cypionka;given-names:A.</infon><offset>28832</offset><text>Membrane fusion intermediates via directional and full assembly of the SNARE complex</text></passage><passage><infon key="name_3">surname:Gulbranson;given-names:D.R.</infon><infon key="name_2">surname:Yu;given-names:H.</infon><infon key="name_1">surname:Rathore;given-names:S.S.</infon><infon key="name_0">surname:Shen;given-names:C.</infon><infon key="fpage">8852</infon><infon key="pub-id_pmid">26572858</infon><infon key="year">2015</infon><infon key="source">Nat. Commun.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Shen;given-names:J.</infon><infon key="name_6">surname:Schoppa;given-names:N.E.</infon><infon key="name_5">surname:Zhang;given-names:C.</infon><infon key="name_4">surname:Hua;given-names:R.</infon><offset>28917</offset><text>The trans-SNARE-regulating function of Munc18-1 is essential to synaptic exocytosis</text><annotation id="3312"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="28956" length="8" /><text>Munc18-1</text></annotation></passage><passage><infon key="name_3">surname:Mozhayeva;given-names:M.</infon><infon key="name_2">surname:Konigstorfer;given-names:A.</infon><infon key="name_1">surname:Deak;given-names:F.</infon><infon key="name_0">surname:Schoch;given-names:S.</infon><infon key="fpage">1117</infon><infon key="pub-id_pmid">11691998</infon><infon key="year">2001</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">294</infon><infon key="section_type">REF</infon><infon key="lpage">1122</infon><infon key="name_6">surname:Kavalali;given-names:E.T.</infon><infon key="name_5">surname:Sudhof;given-names:T.C.</infon><infon key="name_4">surname:Sara;given-names:Y.</infon><offset>29001</offset><text>SNARE function analyzed in synaptobrevin/VAMP knockout mice</text></passage><passage><infon key="name_3">surname:Sudhof;given-names:T.C.</infon><infon key="name_2">surname:Liu;given-names:X.</infon><infon key="name_1">surname:Schoch;given-names:S.</infon><infon key="name_0">surname:Deak;given-names:F.</infon><infon key="fpage">1102</infon><infon key="pub-id_pmid">15475946</infon><infon key="year">2004</infon><infon key="source">Nat. Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="lpage">1108</infon><infon key="name_4">surname:Kavalali;given-names:E.T.</infon><offset>29061</offset><text>Synaptobrevin is essential for fast synaptic-vesicle endocytosis</text></passage><passage><infon key="name_3">surname:R'Bibo;given-names:L.</infon><infon key="name_2">surname:Nakashima;given-names:K.</infon><infon key="name_1">surname:Kamsteeg;given-names:E.J.</infon><infon key="name_0">surname:Mencacci;given-names:N.E.</infon><infon key="fpage">763</infon><infon key="pub-id_pmid">27058447</infon><infon key="year">2016</infon><infon key="source">Am. J. Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">98</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Suzuki;given-names:K.</infon><infon key="name_8">surname:Wiethoff;given-names:S.</infon><infon key="name_7">surname:Adams;given-names:M.E.</infon><infon key="lpage">771</infon><infon key="name_6">surname:Willemsen;given-names:M.A.</infon><infon key="name_5">surname:Balint;given-names:B.</infon><infon key="name_4">surname:Lynch;given-names:D.S.</infon><offset>29126</offset><text>De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions</text></passage><passage><infon key="name_3">surname:Wang;given-names:L.</infon><infon key="name_2">surname:Fan;given-names:Y.</infon><infon key="name_1">surname:Sun;given-names:Y.</infon><infon key="name_0">surname:Huang;given-names:Z.</infon><infon key="fpage">295</infon><infon key="pub-id_pmid">30138938</infon><infon key="year">2018</infon><infon key="source">Cell. Physiol. Biochem.</infon><infon key="type">ref</infon><infon key="volume">49</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Hu;given-names:G.</infon><infon key="name_8">surname:Wang;given-names:Y.</infon><infon key="name_7">surname:Yan;given-names:H.</infon><infon key="lpage">305</infon><infon key="name_6">surname:Wang;given-names:J.</infon><infon key="name_5">surname:Gong;given-names:Z.</infon><infon key="name_4">surname:Liu;given-names:H.</infon><offset>29215</offset><text>Genetic Evaluation of 114 Chinese Short Stature Children in the Next Generation Era: a Single Center Study</text></passage><passage><infon key="name_3">surname:Matilla-Duenas;given-names:A.</infon><infon key="name_2">surname:Camacho;given-names:A.</infon><infon key="name_1">surname:Rodriguez-Garcia;given-names:M.E.</infon><infon key="name_0">surname:Martin-Hernandez;given-names:E.</infon><infon key="fpage">259</infon><infon key="pub-id_pmid">27679995</infon><infon key="year">2016</infon><infon key="source">Neurogenetics</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Arenas;given-names:J.</infon><infon key="name_8">surname:de Las Heras;given-names:R.S.</infon><infon key="name_7">surname:Tejada-Palacios;given-names:P.</infon><infon key="lpage">263</infon><infon key="name_6">surname:Corral-Juan;given-names:M.</infon><infon key="name_5">surname:Quijada-Fraile;given-names:P.</infon><infon key="name_4">surname:Garcia-Silva;given-names:M.T.</infon><offset>29322</offset><text>New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy</text></passage><passage><infon key="name_3">surname:San Antonio-Arce;given-names:V.</infon><infon key="name_2">surname:Nakashima;given-names:K.</infon><infon key="name_1">surname:Perez-Duenas;given-names:B.</infon><infon key="name_0">surname:Salpietro;given-names:V.</infon><infon key="fpage">482</infon><infon key="pub-id_pmid">29392776</infon><infon key="year">2018</infon><infon key="source">Mov. Disord.</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Klein;given-names:C.</infon><infon key="name_8">surname:Mencacci;given-names:N.E.</infon><infon key="name_7">surname:Bettencourt;given-names:C.</infon><infon key="lpage">488</infon><infon key="name_6">surname:Vandrovcova;given-names:J.</infon><infon key="name_5">surname:Efthymiou;given-names:S.</infon><infon key="name_4">surname:Manole;given-names:A.</infon><offset>29466</offset><text>A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea</text></passage><passage><infon key="name_3">surname:Valle;given-names:D.</infon><infon key="name_2">surname:Boehm;given-names:C.</infon><infon key="name_1">surname:Schiettecatte;given-names:F.</infon><infon key="name_0">surname:Sobreira;given-names:N.</infon><infon key="fpage">425</infon><infon key="pub-id_pmid">25684268</infon><infon key="year">2015</infon><infon key="source">Hum. Mutat.</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="section_type">REF</infon><infon key="lpage">431</infon><infon key="name_4">surname:Hamosh;given-names:A.</infon><offset>29558</offset><text>New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene</text></passage><passage><infon key="name_3">surname:Hamosh;given-names:A.</infon><infon key="volume">36</infon><infon key="name_2">surname:Valle;given-names:D.</infon><infon key="name_1">surname:Schiettecatte;given-names:F.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Sobreira;given-names:N.</infon><infon key="fpage">928</infon><infon key="pub-id_pmid">26220891</infon><infon key="year">2015</infon><infon key="source">Hum. Mutat.</infon><infon key="type">ref</infon><infon key="lpage">930</infon><offset>29738</offset><text>GeneMatcher: A matching tool for connecting investigators with an interest in the same gene</text></passage><passage><infon key="name_3">surname:Smith;given-names:C.</infon><infon key="name_2">surname:Walker;given-names:R.</infon><infon key="name_1">surname:Ryten;given-names:M.</infon><infon key="name_0">surname:Trabzuni;given-names:D.</infon><infon key="fpage">275</infon><infon key="pub-id_pmid">21848658</infon><infon key="year">2011</infon><infon key="source">J. Neurochem.</infon><infon key="type">ref</infon><infon key="volume">119</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Hardy;given-names:J.</infon><infon key="lpage">282</infon><infon key="name_6">surname:Weale;given-names:M.E.</infon><infon key="name_5">surname:Ramasamy;given-names:A.</infon><infon key="name_4">surname:Imran;given-names:S.</infon><offset>29830</offset><text>Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies</text></passage><passage><infon key="name_3">surname:Johnston;given-names:R.J.</infon><infon key="name_2">surname:McNew;given-names:J.A.</infon><infon key="name_1">surname:Parlati;given-names:F.</infon><infon key="name_0">surname:Weber;given-names:T.</infon><infon key="fpage">1063</infon><infon key="pub-id_pmid">10831610</infon><infon key="year">2000</infon><infon key="source">J. Cell Biol.</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="section_type">REF</infon><infon key="lpage">1072</infon><infon key="name_6">surname:Rothman;given-names:J.E.</infon><infon key="name_5">surname:Sollner;given-names:T.H.</infon><infon key="name_4">surname:Westermann;given-names:B.</infon><offset>29958</offset><text>SNAREpins are functionally resistant to disruption by NSF and alphaSNAP</text></passage><passage><infon key="name_3">surname:Rothman;given-names:J.E.</infon><infon key="name_2">surname:Paumet;given-names:F.</infon><infon key="name_1">surname:Tareste;given-names:D.C.</infon><infon key="name_0">surname:Shen;given-names:J.</infon><infon key="fpage">183</infon><infon key="pub-id_pmid">17218264</infon><infon key="year">2007</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">128</infon><infon key="section_type">REF</infon><infon key="lpage">195</infon><infon key="name_4">surname:Melia;given-names:T.J.</infon><offset>30030</offset><text>Selective activation of cognate SNAREpins by Sec1/Munc18 proteins</text></passage><passage><infon key="volume">323</infon><infon key="name_1">surname:Rothman;given-names:J.E.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Sudhof;given-names:T.C.</infon><infon key="fpage">474</infon><infon key="pub-id_pmid">19164740</infon><infon key="year">2009</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="lpage">477</infon><offset>30096</offset><text>Membrane fusion: Grappling with SNARE and SM proteins</text></passage><passage><infon key="volume">26</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhang;given-names:Y.</infon><infon key="fpage">1252</infon><infon key="pub-id_pmid">28097727</infon><infon key="year">2017</infon><infon key="source">Protein Sci.</infon><infon key="type">ref</infon><infon key="lpage">1265</infon><offset>30150</offset><text>Energetics, kinetics, and pathway of SNARE folding and assembly revealed by optical tweezers</text></passage><passage><infon key="name_3">surname:Nehring;given-names:R.B.</infon><infon key="name_2">surname:Wei;given-names:S.H.</infon><infon key="name_1">surname:Matti;given-names:U.</infon><infon key="name_0">surname:Sorensen;given-names:J.B.</infon><infon key="fpage">1627</infon><infon key="pub-id_pmid">11830673</infon><infon key="year">2002</infon><infon key="source">Proc. Natl. Acad. Sci. USA</infon><infon key="type">ref</infon><infon key="volume">99</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Rettig;given-names:J.</infon><infon key="name_7">surname:Neher;given-names:E.</infon><infon key="lpage">1632</infon><infon key="name_6">surname:Binz;given-names:T.</infon><infon key="name_5">surname:Ashery;given-names:U.</infon><infon key="name_4">surname:Voets;given-names:T.</infon><offset>30243</offset><text>The SNARE protein SNAP-25 is linked to fast calcium triggering of exocytosis</text></passage><passage><infon key="name_3">surname:Soriano;given-names:S.</infon><infon key="name_2">surname:Chao;given-names:E.S.</infon><infon key="name_1">surname:Chen;given-names:W.</infon><infon key="name_0">surname:Yin;given-names:J.</infon><infon key="fpage">296</infon><infon key="pub-id_pmid">29395075</infon><infon key="year">2018</infon><infon key="source">Am. J. Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Liu;given-names:Z.</infon><infon key="name_8">surname:Pang;given-names:K.</infon><infon key="name_7">surname:Tao;given-names:H.</infon><infon key="lpage">308</infon><infon key="name_6">surname:Cummock;given-names:S.E.</infon><infon key="name_5">surname:Wang;given-names:W.</infon><infon key="name_4">surname:Wang;given-names:L.</infon><offset>30320</offset><text>Otud7a knockout mice recapitulate many neurological features of 15q13.3 microdeletion syndrome</text></passage><passage><infon key="name_3">surname:Goos;given-names:J.A.C.</infon><infon key="name_2">surname:Alvi;given-names:M.</infon><infon key="name_1">surname:Miller;given-names:K.A.</infon><infon key="name_0">surname:Reijnders;given-names:M.R.F.</infon><infon key="fpage">1195</infon><infon key="pub-id_pmid">29861108</infon><infon key="year">2018</infon><infon key="source">Am. J. Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="section_type">REF</infon><infon key="name_9">surname:de Vries;given-names:B.B.A.</infon><infon key="name_8">surname:Mikat;given-names:B.</infon><infon key="name_7">surname:Kraus;given-names:A.</infon><infon key="lpage">1203</infon><infon key="name_6">surname:Henderson;given-names:A.</infon><infon key="name_5">surname:de Burca;given-names:A.</infon><infon key="name_4">surname:Lees;given-names:M.M.</infon><offset>30415</offset><text>De Novo and inherited loss-of-function variants in TLK2: Clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder</text></passage><passage><infon key="name_3">surname:Kurian;given-names:M.A.</infon><infon key="name_2">surname:Cross;given-names:J.H.</infon><infon key="name_1">surname:Howell;given-names:K.B.</infon><infon key="name_0">surname:McTague;given-names:A.</infon><infon key="fpage">304</infon><infon key="pub-id_pmid">26597089</infon><infon key="year">2016</infon><infon key="source">Lancet Neurol.</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="lpage">316</infon><infon key="name_4">surname:Scheffer;given-names:I.E.</infon><offset>30557</offset><text>The genetic landscape of the epileptic encephalopathies of infancy and childhood</text></passage><passage><infon key="volume">17</infon><infon key="name_1">surname:Mencacci;given-names:N.E.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Carecchio;given-names:M.</infon><infon key="fpage">97</infon><infon key="pub-id_pmid">29086067</infon><infon key="year">2017</infon><infon key="source">Curr. Neurol. Neurosci. Rep.</infon><infon key="type">ref</infon><offset>30638</offset><text>Emerging monogenic complex hyperkinetic disorders</text></passage><passage><infon key="name_3">surname:Engel;given-names:A.G.</infon><infon key="volume">83</infon><infon key="name_2">surname:Brengman;given-names:J.</infon><infon key="name_1">surname:Selcen;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Shen;given-names:X.M.</infon><infon key="fpage">2247</infon><infon key="pub-id_pmid">25381298</infon><infon key="year">2014</infon><infon key="source">Neurology</infon><infon key="type">ref</infon><infon key="lpage">2255</infon><offset>30688</offset><text>Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability</text></passage><passage><infon key="name_3">surname:Fujita;given-names:A.</infon><infon key="name_2">surname:Hamanaka;given-names:K.</infon><infon key="name_1">surname:Imagawa;given-names:E.</infon><infon key="name_0">surname:Fukuda;given-names:H.</infon><infon key="fpage">673</infon><infon key="pub-id_pmid">29491473</infon><infon key="year">2018</infon><infon key="source">J. Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kramer;given-names:U.</infon><infon key="name_8">surname:Miyake;given-names:N.</infon><infon key="name_7">surname:Takata;given-names:A.</infon><infon key="lpage">676</infon><infon key="name_6">surname:Mizuguchi;given-names:T.</infon><infon key="name_5">surname:Miyatake;given-names:S.</infon><infon key="name_4">surname:Mitsuhashi;given-names:S.</infon><offset>30786</offset><text>A novel missense SNAP25b mutation in two affected siblings from an Israeli family showing seizures and cerebellar ataxia</text></passage><passage><infon key="name_3">surname:Bumbak;given-names:F.</infon><infon key="name_2">surname:Melland;given-names:H.</infon><infon key="name_1">surname:Gordon;given-names:S.L.</infon><infon key="name_0">surname:Baker;given-names:K.</infon><infon key="fpage">2576</infon><infon key="pub-id_pmid">30107533</infon><infon key="year">2018</infon><infon key="source">Brain</infon><infon key="type">ref</infon><infon key="volume">141</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Rossi;given-names:M.</infon><infon key="name_8">surname:Boyd;given-names:S.G.</infon><infon key="name_7">surname:Turner;given-names:B.J.</infon><infon key="lpage">2591</infon><infon key="name_6">surname:Owen;given-names:D.</infon><infon key="name_5">surname:Jiang;given-names:T.J.</infon><infon key="name_4">surname:Scott;given-names:D.J.</infon><offset>30907</offset><text>SYT1-associated neurodevelopmental disorder: A case series</text><annotation id="3313"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="30907" length="4" /><text>SYT1</text></annotation></passage><passage><infon key="name_3">surname:van Kogelenberg;given-names:M.</infon><infon key="name_2">surname:Grozeva;given-names:D.</infon><infon key="name_1">surname:Gordon;given-names:S.L.</infon><infon key="name_0">surname:Baker;given-names:K.</infon><infon key="fpage">1670</infon><infon key="pub-id_pmid">25705886</infon><infon key="year">2015</infon><infon key="source">J. Clin. Invest.</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Baldeweg;given-names:T.</infon><infon key="name_8">surname:Chong;given-names:W.K.</infon><infon key="name_7">surname:Hurles;given-names:M.E.</infon><infon key="lpage">1678</infon><infon key="name_6">surname:Blair;given-names:E.</infon><infon key="name_5">surname:Pike;given-names:M.</infon><infon key="name_4">surname:Roberts;given-names:N.Y.</infon><offset>30966</offset><text>Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling</text><annotation id="3314"><infon key="identifier">6857</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4122</infon><location offset="30992" length="15" /><text>synaptotagmin-1</text></annotation></passage><passage><infon key="name_3">surname:Meaney;given-names:B.</infon><infon key="name_2">surname:Rainier;given-names:S.</infon><infon key="name_1">surname:Matsushita;given-names:M.</infon><infon key="name_0">surname:Chen;given-names:D.H.</infon><infon key="fpage">597</infon><infon key="pub-id_pmid">15824259</infon><infon key="year">2005</infon><infon key="source">Arch. Neurol.</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="name_10">surname:Raskind;given-names:W.H.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Bird;given-names:T.D.</infon><infon key="name_8">surname:Fink;given-names:J.</infon><infon key="name_7">surname:Lipe;given-names:H.</infon><infon key="lpage">600</infon><infon key="name_6">surname:Wolff;given-names:J.</infon><infon key="name_5">surname:Feleke;given-names:A.</infon><infon key="name_4">surname:Tisch;given-names:L.</infon><offset>31056</offset><text>Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds</text><annotation id="3315"><infon key="identifier">tmVar:p|SUB|A||V;VariantGroup:15;CorrespondingGene:6857;CorrespondingSpecies:9606</infon><infon key="type">ProteinMutation</infon><location offset="31068" length="17" /><text>alanine-to-valine</text></annotation></passage><passage><infon key="name_3">surname:Wei;given-names:W.</infon><infon key="name_2">surname:Xiong;given-names:Z.Q.</infon><infon key="name_1">surname:Lin;given-names:Y.</infon><infon key="name_0">surname:Chen;given-names:W.J.</infon><infon key="fpage">1252</infon><infon key="pub-id_pmid">22101681</infon><infon key="year">2011</infon><infon key="source">Nat. Genet.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Zhang;given-names:Q.J.</infon><infon key="name_8">surname:Chen;given-names:Y.F.</infon><infon key="name_7">surname:He;given-names:J.</infon><infon key="lpage">1255</infon><infon key="name_6">surname:Guo;given-names:S.L.</infon><infon key="name_5">surname:Tan;given-names:G.H.</infon><infon key="name_4">surname:Ni;given-names:W.</infon><offset>31202</offset><text>Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia</text><annotation id="3316"><infon key="identifier">112476</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">114328</infon><location offset="31254" length="5" /><text>PRRT2</text></annotation></passage><passage><infon key="name_3">surname:Calloway;given-names:N.</infon><infon key="name_2">surname:Michelassi;given-names:F.E.</infon><infon key="name_1">surname:Verhoeven-Duif;given-names:N.M.</infon><infon key="name_0">surname:Lipstein;given-names:N.</infon><infon key="fpage">1005</infon><infon key="pub-id_pmid">28192369</infon><infon key="year">2017</infon><infon key="source">J. Clin. Invest.</infon><infon key="type">ref</infon><infon key="volume">127</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Cuppen;given-names:I.</infon><infon key="name_8">surname:van Empelen;given-names:R.</infon><infon key="name_7">surname:van Haelst;given-names:M.M.</infon><infon key="lpage">1018</infon><infon key="name_6">surname:van Haaften;given-names:G.</infon><infon key="name_5">surname:Pienkowska;given-names:K.</infon><infon key="name_4">surname:van Hasselt;given-names:P.M.</infon><offset>31305</offset><text>Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder</text><annotation id="3317"><infon key="identifier">23025</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11279</infon><location offset="31314" length="6" /><text>UNC13A</text></annotation></passage><passage><infon key="name_3">surname:Hamada;given-names:K.</infon><infon key="name_2">surname:Mizuguchi;given-names:T.</infon><infon key="name_1">surname:Kato;given-names:M.</infon><infon key="name_0">surname:Saitsu;given-names:H.</infon><infon key="fpage">782</infon><infon key="pub-id_pmid">18469812</infon><infon key="year">2008</infon><infon key="source">Nat. Genet.</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Nishimura;given-names:A.</infon><infon key="name_8">surname:Nishiyama;given-names:K.</infon><infon key="name_7">surname:Kumada;given-names:S.</infon><infon key="lpage">788</infon><infon key="name_6">surname:Uruno;given-names:K.</infon><infon key="name_5">surname:Tohyama;given-names:J.</infon><infon key="name_4">surname:Osaka;given-names:H.</infon><offset>31405</offset><text>De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy</text><annotation id="3318"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="31452" length="8" /><text>MUNC18-1</text></annotation><annotation id="3319"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="31444" length="6" /><text>STXBP1</text></annotation></passage><passage><infon key="name_3">surname:Accorsi;given-names:P.</infon><infon key="name_2">surname:Willemsen;given-names:M.H.</infon><infon key="name_1">surname:Nikanorova;given-names:M.</infon><infon key="name_0">surname:Stamberger;given-names:H.</infon><infon key="fpage">954</infon><infon key="pub-id_pmid">26865513</infon><infon key="year">2016</infon><infon key="source">Neurology</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Caliebe;given-names:A.</infon><infon key="name_8">surname:Budetta;given-names:M.</infon><infon key="name_7">surname:Benoit;given-names:V.</infon><infon key="lpage">962</infon><infon key="name_6">surname:Benkel-Herrenbrueck;given-names:I.</infon><infon key="name_5">surname:Baier;given-names:H.</infon><infon key="name_4">surname:Angriman;given-names:M.</infon><offset>31509</offset><text>STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy</text><annotation id="3320"><infon key="identifier">6812</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2382</infon><location offset="31509" length="6" /><text>STXBP1</text></annotation></passage><passage><infon key="volume">589</infon><infon key="name_2">surname:Lin;given-names:W.</infon><infon key="name_1">surname:Sugiura;given-names:Y.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Liu;given-names:Y.</infon><infon key="fpage">1603</infon><infon key="pub-id_pmid">21282288</infon><infon key="year">2011</infon><infon key="source">J. Physiol.</infon><infon key="type">ref</infon><infon key="lpage">1618</infon><offset>31581</offset><text>The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction</text><annotation id="3321"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="31608" length="5" /><text>VAMP1</text></annotation></passage><passage><infon key="name_3">surname:Grewal;given-names:K.K.</infon><infon key="name_2">surname:Merner;given-names:N.D.</infon><infon key="name_1">surname:Meijer;given-names:I.A.</infon><infon key="name_0">surname:Bourassa;given-names:C.V.</infon><infon key="fpage">548</infon><infon key="pub-id_pmid">22958904</infon><infon key="year">2012</infon><infon key="source">Am. J. Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Boycott;given-names:K.</infon><infon key="name_8">surname:Jog;given-names:M.</infon><infon key="name_7">surname:Pryse-Phillips;given-names:W.</infon><infon key="lpage">552</infon><infon key="name_6">surname:Ives;given-names:E.J.</infon><infon key="name_5">surname:Hodgkinson;given-names:K.</infon><infon key="name_4">surname:Stefanelli;given-names:M.G.</infon><offset>31693</offset><text>VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families</text><annotation id="3322"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="31693" length="5" /><text>VAMP1</text></annotation></passage><passage><infon key="name_3">surname:Storbeck;given-names:M.</infon><infon key="name_2">surname:Delle Vedove;given-names:A.</infon><infon key="name_1">surname:Lin;given-names:W.</infon><infon key="name_0">surname:Salpietro;given-names:V.</infon><infon key="fpage">597</infon><infon key="pub-id_pmid">28253535</infon><infon key="year">2017</infon><infon key="source">Ann. Neurol.</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Saggar;given-names:A.</infon><infon key="name_8">surname:Ye;given-names:Q.</infon><infon key="name_7">surname:Wiethoff;given-names:S.</infon><infon key="lpage">603</infon><infon key="name_6">surname:Manole;given-names:A.</infon><infon key="name_5">surname:Efthymiou;given-names:S.</infon><infon key="name_4">surname:Liu;given-names:Y.</infon><offset>31775</offset><text>Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome</text><annotation id="3323"><infon key="identifier">6843</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">40678</infon><location offset="31799" length="5" /><text>VAMP1</text></annotation></passage><passage><infon key="name_3">surname:Kay;given-names:C.S.</infon><infon key="name_2">surname:Lorenzoni;given-names:P.J.</infon><infon key="name_1">surname:Scola;given-names:R.H.</infon><infon key="name_0">surname:Shen;given-names:X.M.</infon><infon key="fpage">130</infon><infon key="pub-id_pmid">28168212</infon><infon key="year">2017</infon><infon key="source">Ann. Clin. Transl. Neurol.</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Engel;given-names:A.G.</infon><infon key="lpage">138</infon><infon key="name_6">surname:Selcen;given-names:D.</infon><infon key="name_5">surname:Brengman;given-names:J.</infon><infon key="name_4">surname:Werneck;given-names:L.C.</infon><offset>31856</offset><text>Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome</text></passage><passage><infon key="name_3">surname:Alhassnan;given-names:Z.</infon><infon key="name_2">surname:AlSayed;given-names:M.</infon><infon key="name_1">surname:Abouelhoda;given-names:M.</infon><infon key="name_0">surname:Monies;given-names:D.</infon><infon key="fpage">921</infon><infon key="pub-id_pmid">28600779</infon><infon key="year">2017</infon><infon key="source">Hum. Genet.</infon><infon key="type">ref</infon><infon key="volume">136</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Al-Muhaizea;given-names:M.A.</infon><infon key="name_8">surname:Rahbeeni;given-names:Z.</infon><infon key="name_7">surname:Shah;given-names:A.</infon><infon key="lpage">939</infon><infon key="name_6">surname:Al-Owain;given-names:M.</infon><infon key="name_5">surname:Kayyali;given-names:H.</infon><infon key="name_4">surname:Alotaibi;given-names:M.</infon><offset>31931</offset><text>The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">title_1</infon><offset>32034</offset><text>Accession Numbers</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32052</offset><text>The accession numbers for the DNA sequences reported in this paper are in the Leiden Open Variation Database: 00181522, 00181523, 00181524, 00181525, 00181526.</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">title_1</infon><offset>32212</offset><text>Web Resources</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32226</offset><text>CADD, https://cadd.gs.washington.edu/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32264</offset><text>ClustalX, https://www.ebi.ac.uk/Tools/msa/clustalw2/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32317</offset><text>Ensembl, http://www.ensembl.org/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32350</offset><text>Exome Aggregation Consortium (ExAC), http://exac.broadinstitute.org</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32418</offset><text>Exome Variant Server, http://evs.gs.washington.edu/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32470</offset><text>Exome Variant Server of the National Heart, Lung, and Blood Institute Grand Opportunity (NHLBI GO) Exome Sequencing Project (accessed February 2014), http://evs.gs.washington.edu/EVS/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32654</offset><text>Genome Analysis Toolkit (GATK), https://www.broadinstitute.org/gatk/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32723</offset><text>GenotypeTissue Expression (GTEx) Project, http://www.gtexportal.org</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32791</offset><text>GnomAD, https://gnomad.broadinstitute.org/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32834</offset><text>GTEx, http://www.gtexportal.org/home/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32872</offset><text>Interactive bio-software, https://www.interactive-biosoftware.com/doc/alamut-visual</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>32956</offset><text>NCBI ClinVar database, https://www.ncbi.nlm.nih.gov/clinvar/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>33017</offset><text>Online Mendelian Inheritance in Man (OMIM), http://omim.org/</text><annotation id="3324"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="33054" length="4" /><text>OMIM</text></annotation><annotation id="3325"><infon key="identifier">MESH:D030342</infon><infon key="type">Disease</infon><location offset="33017" length="35" /><text>Online Mendelian Inheritance in Man</text></annotation></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>33078</offset><text>Picard, http://broadinstitute.github.io/picard/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>33126</offset><text>Primer-BLAST, https://www.ncbi.nlm.nih.gov/tools/primer-blast/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>33189</offset><text>UCSC Genome Browser, http://genome.ucsc.edu/</text></passage><passage><infon key="section_type">KEYWORD</infon><infon key="type">paragraph</infon><offset>33234</offset><text>UniProt database, https://www.uniprot.org/</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>33277</offset><text>Supplemental Data</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>33295</offset><text>Supplemental Data can be found online at https://doi.org/10.1016/j.ajhg.2019.02.016.</text></passage><relation id="R1"><infon key="score">0.9442</infon><infon key="role1">Gene|6616</infon><infon key="role2">Gene|6844</infon><infon key="type">Bind</infon></relation><relation id="R2"><infon key="score">0.9996</infon><infon key="role1">Disease|MESH:D000014</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R3"><infon key="score">0.9997</infon><infon key="role1">Disease|MESH:D008607</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R4"><infon key="score">0.9997</infon><infon key="role1">Disease|MESH:D002658</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R5"><infon key="score">0.9996</infon><infon key="role1">Disease|MESH:D009123</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R6"><infon key="score">0.9997</infon><infon key="role1">Disease|MESH:D001321</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R7"><infon key="score">0.9995</infon><infon key="role1">Disease|MESH:D006948</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R8"><infon key="score">0.9994</infon><infon key="role1">Disease|MESH:D014786</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation><relation id="R9"><infon key="score">0.9391</infon><infon key="role1">Gene|6804</infon><infon key="role2">Gene|6844</infon><infon key="type">Bind</infon></relation><relation id="R10"><infon key="score">0.9996</infon><infon key="role1">Disease|MESH:D004827</infon><infon key="role2">Gene|6844</infon><infon key="type">Association</infon></relation></document>
</collection>